無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヘルスケア向けコールドチェーンロジスティクスの世界市場:細胞療法・ワクチン・ヒトの臓器へのフォーカス (2018-2030年)

Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030

発行 ROOTS ANALYSIS 商品コード 710767
出版日 ページ情報 英文 497 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
ヘルスケア向けコールドチェーンロジスティクスの世界市場:細胞療法・ワクチン・ヒトの臓器へのフォーカス (2018-2030年) Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030
出版日: 2018年09月27日 ページ情報: 英文 497 Pages
概要

現在、生物製剤、ワクチン、移植用の人間の臓器、および特定の従来型薬理学的介入といった多種多様な医薬品は温度に敏感であり、輸送には凍結/極低温保持温度を必要としています。 実際、認可済み生物製剤の95%およびワクチンの90%がコールドチェーンに依存しています。

当レポートでは、世界のヘルスケア向けコールドチェーンロジスティクスサービス市場における現在の情勢および将来の展望について調査しており、全体的な市場情勢の分析、様々なロジスティクスサービスプロバイダーの競争力の分析、主要なコールドチェーンロジスティクスサービスプロバイダーのプロファイル、規制ガイドラインについての議論、ケーススタディ、需要予測、および今後見込まれるツール/技術に関する議論などについてまとめています。

第1章 序論

第2章 エグゼクティブサマリー

第3章 イントロダクション

第4章 細胞療法・ワクチン・ヒトの臓器向けコールドチェーンロジスティクス

  • 本章の概要
  • 細胞療法向けコールドチェーン管理
  • ワクチン向けコールドチェーン管理
  • ヒトの臓器向けコールドチェーン管理
  • 各種製品の物流上の難しさの分析

第5章 市場情勢

  • 本章の概要
  • コールドチェーンロジスティクスサービスプロバイダー:企業リスト
  • その他ヘルスケア製品向けコールドチェーンロジスティクスサービスプロバイダーのリスト
  • コールドチェーンロジスティクス向け装置/技術のリスト

第6章 企業競争力の分析

  • 本章の概要
  • 調査手法
  • 主要パラメーターの前提条件
  • コールドチェーンロジスティクスサービスプロバイダー:競合情勢

第7章 企業プロファイル

  • 本章の概要
  • Cryoport
  • Lynden International Logistics
  • PAREXEL
  • DHL Express
  • United Parcel Service
  • GAC
  • Yusen Logistics

第8章 近年の提携・拡大

  • 本章の概要
  • 提携モデル
  • 提携・コラボレーションのリスト
  • M&A
  • 近年の拡大

第9章 規制提言・ガイドライン

  • 本章の概要
  • 国際当局による規制ガイドライン
  • 米国におけるコールドチェーン管理向け規制ガイドライン
  • カナダにおけるコールドチェーン管理向け規制ガイドライン
  • 欧州におけるコールドチェーン管理向け規制ガイドライン
  • コールドチェーンロジスティクスの各段階に向けた提言
  • 規制当局の比較分析

第10章 ケーススタディ:認可済み医薬品向けコールドチェーンの要件

  • 本章の概要
  • USFDA認可薬のリスト

第11章 細胞療法向け需要分析

  • 本章の概要
  • 調査範囲・手法
  • 細胞療法、世界の臨床需要:治験数による分析
  • 細胞療法、世界の臨床需要:登録患者数による分析
  • 細胞療法、世界の臨床需要:予測される認可済み製品数による分析
  • 細胞療法、世界の臨床需要:ターゲット患者人口による分析
  • 結論

第12章 ワクチン向け需要分析

  • 本章の概要
  • 調査範囲・手法
  • ワクチン、世界の臨床需要:治験数による分析
  • ワクチン、世界の臨床需要:登録患者数による分析
  • ワクチン、世界の臨床需要:ワクチンタイプによる分析
  • ワクチン、世界の臨床需要:患者数による分析
  • ワクチン、世界の臨床需要:投薬量による分析
  • 結論

第13章 ヒトの臓器向け需要分析

  • 本章の概要
  • 調査範囲・手法
  • 細胞療法、世界の需要:地域分布
  • 細胞療法、世界の需要:臓器のタイプによる分析
  • 細胞療法、世界全体の需要
  • 結論

第14章 市場予測

  • 本章の概要
  • 予測手法・主な前提条件
  • 世界のコールドチェーンロジスティクス市場
  • 世界のコールドチェーンロジスティクス市場:製品タイプ別
  • 世界のコールドチェーンロジスティクス市場:保持温度範囲別
  • 世界のコールドチェーンロジスティクス市場:容器タイプ別
  • 世界のコールドチェーンロジスティクス市場:エンドユーザータイプ別
  • 世界のコールドチェーンロジスティクス市場:地域別
  • 世界のコールドチェーンロジスティクス市場:製品タイプ・地域別
  • 世界のコールドチェーンロジスティクス市場:保持温度範囲・地域別
  • 世界のコールドチェーンロジスティクス市場:容器・地域別
  • 世界のコールドチェーンロジスティクス市場:エンドユーザータイプ・地域別
  • 世界のコールドチェーンロジスティクス市場:製品・エンドユーザータイプ別
  • 結論

第15章 SWOT分析

  • 本章の概要
  • 強み
  • 弱み
  • 機会
  • 脅威
  • SWOT要因の比較

第16章 近い将来の動向・将来の成長機会

  • 本章の概要
  • コネクテッドコールドチェーン:主要ツール・技術
  • コネクテッドコールドチェーン:将来の成長機会
  • リアルタイムモニタリング:コネクテッドコールドチェーンロジスティクスのアプリケーション

第17章 重要考察

  • 本章の概要
  • AirBridgeCargo Airlines
  • Cell and Gene Therapy Catapult
  • UNICEF
  • Tabuk Pharmaceuticals

第18章 付録1:図表データ

第19章 企業・組織リスト

目次
Product Code: RA100119

The origins of the cold chain for transportation of temperature sensitive products can be traced back to 1797, when British fishermen first used natural ice to preserve their fish stock. Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures for transport. In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain dependent. Other healthcare products which are required to be shipped / stored under specific temperature conditions include aerosols, blood plasma samples, certain types of diagnostics kits, fertility samples, and laboratory specimens. For some products, even the slightest variations in temperature / storage conditions can adversely alter their integrity and / or viability.

Over the years, the growing demand for such products has necessitated the need for well-defined infrastructure and protocols to support cold chain dependent logistics operations. Further, stakeholders in this segment of the industry have designed and established a variety of innovative solutions to serve the evolving demands of the healthcare sector. Moreover, connected cold chain solutions have been observed to offer a variety of advantages over conventional methodologies, such as automation of most of the steps and elimination of human handling errors that are associated with human intervention.

In addition, the industry has witnessed several facility / capability expansions and acquisitions owing to an increasing demand for cold chain logistics services, which is indicative of the growing interest of stakeholders in this particular type of supply chain. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.

Synopsis:

The “Cold Chain Logistics Market for Healthcare: Focus on Cell Therapies, Vaccines, and Human Organs, 2018-2030” report features an extensive study of the current landscape and future outlook of the growing cold chain logistics services market. The study features an in-depth analysis, highlighting the capabilities of the various service providers engaged in this domain. Amongst other elements, the report features:

  • An analysis comparing the logistical complexities associated with cell therapies, vaccines and human organs, based on several parameters, such as holding temperatures, delivery time restrictions, handling / transportation requirements, and storage related needs.
  • A detailed assessment of the overall market landscape, featuring a comprehensive list of over 80 players that offer cold chain logistics services for cell therapies, vaccines and human organs, and detailed analyses based on a number of parameters, such as the location of headquarters, size of employee base, type of products (cell therapies, vaccines, human organs, pharmaceutical products, and others), type of services offered (storage, packaging, and transportation), mode of transportation (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging methods (dry ice, liquid nitrogen, and gel packs), type of container (active and passive containers), type of end-users (industry players and non-industry players), geographical activity and location of cold chain facilities.
  • An insightful 2X2 representation of the results of a competitiveness analysis of various logistics service providers (segregated into three peer groups based on their employee count (small-sized (1-200 employees), mid-sized (>201-1,000 employees) and large (>1,000 employees)), highlighting capable players in this domain, based on their cold chain logistics capabilities (such as type(s) of container, type(s) of service(s) offered, holding temperature range, modes of transportation employed, geographical activity and type(s) of cold chain product(s)) and supplier power.
  • Elaborate profiles of leading cold chain logistics service providers (shortlisted on the basis of the company competitiveness analysis), featuring an overview of the company, its financial information (if available), funding information (if available), information on cold chain logistics service(s) / product(s), recent partnerships, and a comprehensive future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering service alliances, logistics service agreements, merger / acquisitions, equipment development / manufacturing agreements, R&D agreements, and joint ventures.
  • A detailed discussion on the various regulatory guidelines that have been laid down by major regulatory bodies (such as European Medicines Agency (EMA), United States Food and Drug Administration (USFDA), Health Canada (HC), International Air Transport Association (IATA), International Council for Harmonisation (ICH), International Safe Transit Association (ISTA), Parenteral Drug Association (PDA), United States Pharmacopeia (USP), and World Health Organization (WHO)), specific to cold chain management. In addition, it features an insightful analysis, comparing regulatory authorities based on the guidelines issued by them for different stages of the cold chain.
  • A case study on the cold chain management strategies used for over 190 drugs (both biologics and small molecules)that were approved in the last five years, highlighting year-wise trend of cold chain adoption. In addition, it analyzes the cold chain temperature requirements of these drugs, based on several parameters, including type of molecule(s), dosage form and route of administration.
  • A detailed estimation of the likely demand for logistics services for [A] cell therapies (including stem cell therapies, T-cell therapies, dendritic cell therapies, natural killer cell therapies and tumor therapies), considering the contributions of clinical and commercial stage products over the period 2018-2030; [B] vaccines (including over 15 types of mandatory and optional vaccines), considering the contributions of both clinical and commercially available products for both infants and adults, over the period 2018-2030; and [C] human organs (including heart, intestine, kidney, liver, lung, and pancreas) for transplants, over the period 2018-2030.
  • A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under a comprehensive SWOT framework. It also includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall cold chain logistics market.
  • A discussion on the upcoming tools / technologies (such as integration of automation and robotics, cloud computing, blockchain technology, artificial intelligence and other such advanced technical solutions) in the field of cold chain logistics and their likely impact on the future evolution of this market.

One of the key objectives of the report was to estimate the existing market size and potential growth opportunities for cold chain logistics over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2018-2030. In addition, we have provided the likely distribution of the future opportunity based on [A] regional evolution of the market covering key geographies, such as North America (the US, Canada and Mexico), Europe (the UK, Germany, France, Germany, Spain and Italy), Asia-Pacific and Rest of the World (Australia, China, India, and Japan), [B] type of products (cell therapies, vaccines, and human organs), [C] holding temperature ranges (refrigerated, frozen, and cryogenic), [D] type of containers (active and passive containers), and [E] type of end-users (industry players and non-industry players). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

  • Elena Boykova (Marketing Communications Manager, AirBridgeCargo Airlines)
  • Jacqueline Barry (Chief Clinical Officer, Catapult Cell and Gene Therapy)
  • Michelle Arnot-Kruger (Health Specialist, Cold Chain Logistics, UNICEF)
  • Shehdeh Abusnineh (Supply Chain Manager, Tabuk Pharmaceuticals).

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Example Highlights:

  • 1. Over 85 players are currently offering cold chain logistics services for cell therapies, vaccines and human organs across a wide range of recommended holding temperatures; of these, majority of the companies offer services to transport products at ambient and refrigerated temperatures (70+ each), followed by players that offer services at frozen (60+) and cryogenic temperatures (30+). Examples of players engaged in this domain include (in alphabetical order, no selection criteria) Air Liquide Company, American Airlines Cargo, Cryoport, DHL Express, PAREXEL, and United Parcel Service.
  • 2. The market is characterized by the presence of several established as well as emerging players. Of the total, 43% are large companies (more than 1,000 employees), 16% are mid-sized companies (201-1,000 employees), while 41% are small-sized players (less than 200 employees). Examples of some of the established players (with more than 25 years of experience in the industry) include (in alphabetical order, no selection criteria) Bollore Logistics, Cardinal Health, DHL International, FedEx Express, GAC, Kuehne and Nagel International, Yusen Logistics, and Zuellig Pharma. On the other hand, some of the players that have recently entered this domain include (in alphabetical order, no selection criteria) Accelogix, Arcticold Logistics, Biotech & Pharma Logistics, Camio Logistics Solutions and Cold Box Express.
  • 3. Over 40% of all drugs (small molecules and biologics) that have been approved so far in 2018 are cold chain dependent, having different holding temperature requirements for transportation. Particularly, within biologics, all the approved monoclonal antibodies and cell therapies are cold chain dependent. Examples of recently approved biologics that are cold chain dependent include LUXTURNA®,KYMRIAH® and YESCARTA®.
  • 4. Specifically, for cell therapies, the current global commercial demand for cold chain logistics services is primarily driven by autologous therapies, which account for 83% of the currently approved cell therapies. However, in future (by 2030), as more of such therapy products are approved, the demand for cold chain logistics services is likely to increase significantly. In terms of clinical scale requirements, the demand for cell therapies is driven by over 1,000 active clinical trials, with 1,19,000+ enrolled patients, focused on evaluating different types of cell therapies in multiple centers / hospitals / institutions across the globe.
  • 5. For vaccines, the current clinical demand is based on the requirement of these products in close to 1,300 trials that have been registered (ongoing / planned) across different geographies. Based on the number of trials, North America (~750 trials) has emerged as a major research / innovation hub in this domain; it is also worth highlighting that about 74% of the total number of patients enrolled in the aforementioned trials have been recruited in centers in Asia-Pacific and rest of the world.
  • 6. Specifically, for human organs, around 140,000 organ transplants take place annually across the globe. Presently, kidneys are the most common type of human organ being transplanted (65%), followed by liver (23%). However, lung transplants are likely to witness the maximum CAGR (~ 7%) between 2018 and 2030.
  • 7. A growing number of partnerships have been forged between logistics service providers and developer companies and / or other logistics service providers during the period 2014-H1 2018. It is worth mentioning that most of these partnerships were service alliances (36%). logistics service agreements (27%) are the next most popular partnerships, through which developer companies have recruited the services of logistics services providers. This is followed by mergers / acquisitions accounting for 24% of the total number of deals. Prominent logistics service providers that have entered into multiple partnerships in the given time period, include (in alphabetical order) Cryoport, Brooks Life Sciences, CSafe Global, TrakCel and Tower Cold Chain Solutions.
  • 8. Amidst increasing competition in this domain, logistics service providers are actively investigating and adopting several innovative tools / techniques in order to expedite the controlled delivery of temperature sensitive products and improve the overall productivity. Examples of such tools / technologies (in no specific order) include automation and robotics, augmented reality, cloud computing, blockchain technology, artificial intelligence and other such advanced technical solutions. Examples of companies that are presently offering such tools / techniques include (in alphabetical order, no selection criteria) CargoSense, DeltaTrak, Dynamox, Entera Solutions, NexG, OpenPort, SwanLeap, TAG Sensors, and ZilionSouce Technologies.
  • 9. The market for cold chain logistics is expected to grow at an annualized rate of over 9.8% between 2018 and 2030. While logistics services for cell therapies are expected to capture the majority share in the market, the vaccines segment is anticipated to witness a relatively faster growth rate. In terms of products, those that are required to be stored / transported at cryogenic and frozen temperatures are estimated to capture a significant proportion of the current market.
  • 10. North America (primarily the US) and Europe currently hold the larger share (over 60%) in the overall cold chain logistics market. This is followed by Asia-Pacific and the rest of the world, which currently capture around 40% of the overall market share. We are led to believe that this trend is not likely to change significantly in the foreseen future.

Research Methodology:

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2030, the report also provides our independent view on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

Chapter Outlines:

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the state of the healthcare cold chain logistics market in the short to mid-term and long term.

Chapter 3 is an introductory chapter that provides a detailed comparison of the traditional supply chain and cold chain, along with information on the various processes and procedures associated with cold chain logistics, including a discussion on its historical evolution. It also elaborates on the key steps involved in cold chain logistics operations of temperature-sensitive healthcare products, including cold chain storage, packaging, transportation and monitoring. Further, the chapter provides a brief overview of different kinds of healthcare products, which require cold chain operations, along with the preferred storage / transportation temperature ranges for each product. It also features a comprehensive discussion on the various modes of transportation used for such shipments. Further, the chapter features a discussion on the various advantages and limitations associated with the cold chain logistics and management industry.

Chapter 4 features a detailed discussion on various complexities associated with the cold chain logistics operations for cell therapies, vaccines and human organs. It also highlights the criticality of cold chain logistics during product manufacturing, storage, packaging and transportation. Furthermore, it provides information on recommended cold chain temperature profiles and best practices for shipping and storage of the aforementioned product types. The chapter also elaborates on the various challenges related to cold chain logistics operations and their solutions. It includes two case studies of recent advancements, namely cell orchestration platforms for management of cell therapy logistics and innovative beating heart-in-a-box technology for efficient human organ logistics. It also includes an informative multi-valent analysis to compare the logistical complexities related to cell therapies, vaccines and human organs based on several parameters, such as temperature conditions, delivery time restrictions, handling / transportation requirements, and storage related needs.

Chapter 5 includes a comprehensive market landscape analysis of companies that offer cold chain logistics services, particularly for the shipping of cell therapies, vaccines and human organs. The chapter presents detailed analyses on the basis of the location of their headquarters, employee count, type of products (cell therapies, vaccines, human organs, pharmaceutical products, and others), type of services offered (storage, packaging, and transportation), mode of transportation (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging methods (dry ice, liquid nitrogen, and gel packs), type of container (active and passive containers), type of end-users (industry players and non-industry players), geographical activity and location of cold chain facilities. The chapter also provides a list of cold chain equipment / technologies and monitoring systems, along with their developers. Further, it includes an indicative list of players offering cold chain logistics for other pharmaceutical products, and a list of companies that are acting as air ambulances for the transportation of human organs.

Chapter 6 features a comprehensive 2X2 analysis offering a comparative summary of all the cold chain logistics service providers that we came across during our research. The analysis compares the aforementioned companies within three peer-groups, established based on size of employee base (small-sized (1-200 employees), mid-sized (>201-1,000 employees) and large (>1,000 employees)). The companies were compared based on their cold chain logistics capabilities, such as type(s) of container, type(s) of service(s) offered, holding temperature range, modes of transportation employed, geographical activity and type(s) of cold chain product(s) and supplier power.

Chapter 7 provides detailed profiles of some of the important cold chain logistics providers (shortlisted on the basis of the company competitiveness analysis), based in different geographies. Each company profile includes a brief overview of the company, financial information (if available), funding information (if available), details on its cold chain logistics service(s) / product(s) capabilities, recent partnerships, and a comprehensive future outlook.

Chapter 8 features an elaborate discussion and analysis of the various partnerships / collaborations that have been inked amongst players in this market. It includes a brief description on the various types of partnership models (such as service alliances, logistics service agreements, merger / acquisitions, equipment development / manufacturing agreements, R&D agreements, and joint ventures) that have been employed by stakeholders in this domain, and analysis on the trend of partnerships inked since 2014. It also consists of a schematic representation showcasing the service providers that have established the maximum number of alliances. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents. In addition, it includes an analysis of the mergers and acquisitions that have taken place in the last five years. The chapter also highlights the recent facility expansions undertaken by cold chain logistics providers in the given time period.

Chapter 9 provides information on the regulatory guidelines that have been laid down by key regulatory bodies / organizations, specific to cold chain management in the healthcare industry. These include EMA, USFDA, HC, IATA, ICH, ISTA, PDA, USP, and WHO. In addition, it features an insightful analysis, comparing different regulatory authorities, based on the guidelines issued by them for different stages of the cold chain.

Chapter 10 presents a case study on the cold chain management strategies for over 190 drugs (both biologics and small molecules) approved by the USFDA from 2014 to 2018 (till July), highlighting year-wise trend of cold chain adoption. The chapter comprises of in-depth analyses, highlighting the cold chain temperature requirements of these drugs, based on several parameters, including type of molecule(s), dosage form and route of administration. Furthermore, we have also highlighted the leading players in this domain, based on the number of cold chain drug approvals received in the given time period.

Chapter 11 features a holistic view on the demand for cell therapy products (both clinical and commercial stage) in the market, allowing us to present an informed opinion on the required scale of supply (in terms of cold chain logistics support). For the purpose of estimating the current clinical demand, we looked at the active clinical studies that have been registered in the last five years for different types of cell therapy product candidates, including stem cell therapies, T-cell therapies, dendritic cell therapies, natural killer cell therapies and tumor therapies. Further, the data was analyzed on the basis of various parameters, such as number of trials, type of cell therapies, regional distribution, leading industry and non-industry players, key indications, and enrolled patient population across different geographies. In order to estimate the commercial demand, we looked at the currently available and late-stage cell therapies across the aforementioned classes, which are expected to receive approval in the coming decade.

Chapter 12 features a holistic view on the demand for vaccines (both clinical and commercially available) in the market, allowing us to present an informed opinion on the required scale of supply (in terms of cold chain logistics support). For the purpose of estimating the current clinical demand, we looked at the active clinical studies that have been registered in the last five years for different types of vaccines. Further, the data was analyzed on the basis of various parameters, such as number of trials, recommended holding temperature, regional distribution, leading industry and non-industry players, and enrolled patient population across different geographies. In order to estimate the commercial demand, we looked at the commercially available vaccines (both mandatory and optional) that are shipped in different countries across the globe, to be administered to the patients (both infants and adults), over the period 2018-2030.

Chapter 13 features a detailed analysis of the current demand for cold chain logistics for human organs, wherein we considered the actual transplants, patients on the waiting list and available donors for vital human organs (including heart, kidney, liver, lung, and intestine / pancreas), across different geographies.

Chapter 14 features a comprehensive market forecast, highlighting the future potential of cold chain logistics market till 2030. We have segmented the market on the basis of [A] regional evolution of the market covering key geographies, such as North America (the US, Canada and Mexico), Europe (the UK, Germany, France, Germany, Spain and Italy), Asia-Pacific and Rest of the World (Australia, China, India, and Japan), [B] type of products (cell therapies, vaccines, and human organs), [C] holding temperature ranges (refrigerated, frozen, and cryogenic), [D] type of containers (active and passive containers), and [E] type of end-users (industry players and non-industry players).

Chapter 15 provides a detailed analysis capturing the key parameters and trends that are likely to influence the future of cold chain management in the healthcare industry, under a comprehensive SWOT framework.

Chapter 16 provides a discussion on the upcoming tools / technologies, which are being developed / adopted by the cold chain logistics service providers, that are likely to have a notable influence on the industry's evolution over the coming decade. These include (but not limited to) integration of automation and robotics, augmented reality, cloud computing, internet of things (IoT), radio frequency identification (RFID), blockchain technology, artificial intelligence and big data analytics. In addition,the chapter presents an exemplary list of players that are offering the aforementioned technologies for cold chain logistics to the healthcare and pharmaceutical industry. It also features a qualitative Harvey ball analysis to project their adoption in cold chain industry in the short and long term.

Chapter 17 is a collection of executive insights of the discussions that were held with key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with Elena Boykova (Marketing Communications Manager, AirBridgeCargo Airlines), Jacqueline Barry (Chief Clinical Officer, Catapult Cell and Gene Therapy), Michelle Arnot-Kruger (Health Specialist, Cold Chain Logistics, UNICEF), and Shehdeh Abusnineh (Supply Chain Manager, Tabuk Pharmaceuticals).

Chapter 18 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 19 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Concept of Cold Chain Logistics
    • 3.2.1. Comparison of Conventional Supply Chain and Cold Chain
    • 3.2.2. Historical Evolution of the Cold Chain Logistics Industry
  • 3.3. Cold Chain Logistics in Healthcare
  • 3.4. Types of Healthcare Products Requiring Cold Chain Logistics
  • 3.5. Types of Container used in Cold Chain Logistics
    • 3.5.1. Active Cold Chain Containers
    • 3.5.2. Passive Cold Chain Containers
    • 3.5.3. Insulated Cold Chain Containers
  • 3.6. Modes of Transportation
    • 3.6.1. Road Transportation
    • 3.6.2. Air Transportation
    • 3.6.3. Ocean / Marine Transportation
    • 3.6.4. Rail Transportation
    • 3.6.5. Intermodal and Multimodal Transportation
    • 3.6.6. Comparison of Modes of Transportation
  • 3.7. Advantages and Limitations of Cold Chain Logistics in Healthcare
  • 3.8. Concluding Remarks

4. COLD CHAIN LOGISTICS FOR CELL THERAPIES, VACCINES AND HUMAN ORGANS

  • 4.1. Chapter Overview
  • 4.2. Cold Chain Management for Cell Therapies
    • 4.2.1. An Introduction to Cell Therapies
    • 4.2.2. Classification of Cell Therapies
    • 4.2.3. An Overview of Cell Therapy Logistics
      • 4.2.3.1. Cold Chain Logistics for Autologous Cell Therapies
      • 4.2.3.2. Cold Chain Logistics for Allogeneic Cell Therapies
      • 4.2.3.3. Comparison of Cold Chain Logistics for Autologous and Allogenic Cell Therapies
    • 4.2.4. Cold Storage of Cell Therapies
    • 4.2.5. Challenges Related to Cell Therapy Logistics
      • 4.2.5.1. Process Standardization
      • 4.2.5.2. Packaging and Shipping Qualifications
      • 4.2.5.3. Validation of Storage Containers
      • 4.2.5.4. Logistical Process Qualification
      • 4.2.5.5. Chain-of-Custody Documentation
    • 4.2.6. Strategies to Overcome Existing Challenges in Cell Therapy Logistics
    • 4.2.7. Case-in-Point: Cell Orchestration Platforms for Management of Cell Therapy Logistics
  • 4.3. Cold Chain Management for Vaccines
    • 4.3.1. An Introduction to Vaccines
    • 4.3.2. Classification of Vaccines
    • 4.3.3. An Overview of Vaccine Logistics
    • 4.3.4. Cold Storage of Vaccines
    • 4.3.5. Challenges Related to Vaccine Logistics
      • 4.3.5.1. Heat Sensitivity
      • 4.3.5.2. Cross-Border Shipments
      • 4.3.5.3. Choice of Suitable Containers
  • 4.4. Cold Chain Management for Human Organs
    • 4.4.1. An Introduction to Human Organ Transplantation
    • 4.4.2. An Overview of Human Organ Logistics
    • 4.4.3. Storage / Preservation of Human Organs
    • 4.4.4. Challenges Related to Human Organ Logistics
      • 4.4.4.1. Organ Matching
      • 4.4.4.2. Organ Viability
      • 4.4.4.3. Organ Packaging, Labelling and Transportation
    • 4.4.5. Case-in-Point: Beating Heart-in-a-Box
  • 4.5. Logistical Complexity Analysis for Different Products

5. MARKET LANDSCAPE

  • 5.1. Chapter Overview
  • 5.2. Cold Chain Logistics Service Providers: List of Industry Players
    • 5.2.1. Analysis by Year of Establishment
    • 5.2.2. Analysis by Location of Headquarters
    • 5.2.3. Analysis by Size of Company
    • 5.2.4. Analysis by Type of Products
    • 5.2.5. Analysis by Type of Cold Chain Logistics Service(s)
    • 5.2.6. Analysis by Mode of Transportation
    • 5.2.7. Analysis by Holding Temperature Range
    • 5.2.8. Analysis by Type of Containers
    • 5.2.9. Analysis by Type of End-Users
    • 5.2.10. Analysis by Geographical Activity
    • 5.2.11. Analysis by Location of Cold Chain Facility
  • 5.3. List of Cold Chain Logistics Service Providers for Other Healthcare Products
  • 5.4. List of Equipment / Technologies for Cold Chain Logistics

6. COMPANY COMPETITIVENESS ANALYSIS

  • 6.1. Chapter Overview
  • 6.2. Methodology
  • 6.3. Assumptions and Key Parameters
  • 6.4. Cold Chain Logistics Service Providers: Competitive Landscape
    • 6.4.1. Small-sized Companies
    • 6.4.2. Mid-sized Companies
    • 6.4.3. Large Companies

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Cryoport
    • 7.2.1. Company Snapshot
    • 7.2.2. Financial Information
    • 7.2.3. Cold Chain Logistics Services / Products
    • 7.2.4. Recent Partnerships
    • 7.2.5. Future Outlook
  • 7.3. Lynden International Logistics
    • 7.3.1. Company Snapshot
  • 7.32. Cold Chain Logistics Services / Products
    • 7.3.3. Future Outlook
  • 7.4. PAREXEL
    • 7.4.1. Company Snapshot
    • 7.4.2. Financial Information
    • 7.4.3. Cold Chain Logistics Services / Products
    • 7.4.4. Future Outlook
  • 7.5. DHL Express
    • 7.5.1. Company Snapshot
    • 7.5.2. Financial Information
    • 7.5.3. Cold Chain Logistics Services / Products
    • 7.5.4. Recent Partnerships
    • 7.5.5. Future Outlook
  • 7.6. United Parcel Service
    • 7.6.1. Company Snapshot
    • 7.6.2. Financial Information
    • 7.6.3. Cold Chain Logistics Services / Products
    • 7.6.4. Recent Partnerships
    • 7.6.5. Future Outlook
  • 7.7. GAC
    • 7.7.1. Company Snapshot
    • 7.7.2. Cold Chain Logistics Services / Products
    • 7.7.3. Future Outlook
  • 7.8. Yusen Logistics
    • 7.8.1. Company Snapshot
    • 7.8.2. Financial Information
    • 7.8.3. Cold Chain Logistics Services / Products
    • 7.8.4. Recent Partnerships
    • 7.8.5. Future Outlook

8. RECENT PARTNERSHIPS AND EXPANSIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Cold Chain Logistics in Healthcare: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Type of Product
    • 8.3.4. Analysis by Type of Cold Chain Logistics Service
    • 8.3.5. Analysis by Type of Cold Chain Logistics Service and Type of Product
    • 8.3.6. Most Active Players: Analysis by Number of Partnerships
    • 8.3.7. Regional Analysis
      • 8.3.7.1. Intercontinental and Intracontinental Agreements
  • 8.4. Cold Chain Logistics in Healthcare: Mergers and Acquisitions
    • 8.4.1. Year-Wise Trend
    • 8.4.2. Most Active Acquirers: Analysis by Number of Acquisitions
  • 8.5. Cold Chain Logistics in Healthcare: Recent Expansions

9. REGULATORY RECOMMENDATIONS AND GUIDELINES

  • 9.1. Chapter Overview
  • 9.2. Regulatory Guidelines Issued by International Authorities
    • 9.2.1. World Health Organization (WHO)
    • 9.2.2. International Air Transport Association (IATA)
    • 9.2.3. International Committee on Harmonisation (ICH)
    • 9.2.4. International Safe Transit Association (ISTA)
    • 9.2.5. Parenteral Drug Association (PDA)
  • 9.3. Regulatory Guidelines for Cold Chain Management in the US
    • 9.3.1. United States Food and Drug Administration (USFDA)
    • 9.3.2. United States Pharmacopeia (USP)
  • 9.4. Regulatory Guidelines for Cold Chain Management in Canada
    • 9.4.1. Health Canada
  • 9.5. Regulatory Guidelines for Cold Chain Management in Europe
    • 9.5.1. European Medicine Agency (EMA)
  • 9.6. Recommendations for Different Steps of Cold Chain Logistics
  • 9.7. Comparative Analysis of Regulatory Authorities

10. CASE STUDY: COLD CHAIN REQUIREMENTS FOR APPROVED DRUGS

  • 10.1. Chapter Overview
  • 10.2. List of USFDA Approved Drugs
    • 10.2.1. Analysis by Year of Approval
    • 10.2.2. Analysis by Type of Molecule
    • 10.2.3. Analysis by Type of Biologic
    • 10.2.4. Analysis by Holding Temperature Range
    • 10.2.5. Analysis by Dosage Form and Holding Temperature Range
    • 10.2.6. Analysis by Route of Administration and Holding Temperature Range
    • 10.2.7. Most Active Players: Analysis by Number of Approved Drugs Requiring Cold Chain

11. DEMAND ANALYSIS FOR CELL THERAPIES

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Cell Therapies, Global Clinical Demand: Analysis by Number of Trials
    • 11.3.1. Analysis by Trial Registration Year
    • 11.3.2. Analysis by Type of Cell Therapy
    • 11.3.3. Analysis by Trial Phase
    • 11.3.4. Analysis by Type of Cell Therapy and Trial Phase
    • 11.3.5. Analysis by Therapeutic Indications
    • 11.3.6. Geographical Analysis by Number of Clinical Trials
    • 11.3.7. Geographical Analysis by Type of Cell Therapy and Trial Phase
    • 11.3.8. Analysis by Type of Sponsors / Collaborators
    • 11.3.9. Most Active Players
  • 11.4. Cell Therapies, Global Clinical Demand: Analysis by Enrolled Patient Population
    • 11.4.1. Analysis by Type of Cell Therapy
    • 11.4.2. Geographical Analysis by Enrolled Patient Population
    • 11.4.3. Geographical Analysis by Type of Cell Therapy and Trial Phase
  • 11.5. Cell Therapies, Global Commercial Demand: Analysis by Expected Number of Product Approvals
  • 11.6. Cell Therapies, Global Commercial Demand: Analysis by Target Patient Population
  • 11.7. Concluding Remarks

12. DEMAND ANALYSIS FOR VACCINES

  • 12.1. Chapter Overview
  • 12.2. Scope and Methodology
  • 12.3. Vaccines, Global Clinical Demand: Analysis by Number of Trials
    • 12.3.1. Analysis by Trial Registration Year
    • 12.3.2. Analysis by Holding Temperature Range
    • 12.3.3. Analysis by Trial Phase
    • 12.3.4. Analysis by Trial Status
    • 12.3.5. Geographical Analysis by Number of Clinical Trials
    • 12.3.6. Geographical Analysis by Trial Status and Trial Phase
    • 12.3.7. Analysis by Type of Sponsors / Collaborators
    • 12.3.8. Most Active Players
  • 12.4. Vaccines, Global Clinical Demand: Analysis by Enrolled Patient Population
    • 12.4.1. Geographical Analysis by Enrolled Patient Population
    • 12.4.2. Geographical Analysis of Enrolled Patient Population by Trial Phase and Holding Temperature Range
  • 12.5. Vaccines, Global Commercial Demand: Analysis by Type of Vaccine
    • 12.5.1. Demand for Mandatory Vaccines: Global Scenario
    • 12.5.2. Demand for Mandatory Vaccines: Distribution by Geography
      • 12.5.2.1. Present Demand (2018 Scenario)
      • 12.5.2.2. Estimated Demand in the Short Term (2025 Scenario)
      • 12.5.2.3. Estimated Demand in the Long Term (2030 Scenario)
    • 12.5.3. Demand for Optional Vaccines: Global Scenario
    • 12.5.4. Demand for Optional Vaccines: Distribution by Geography
    • 12.5.4.1. Present Demand (2018 Scenario)
    • 12.5.4.2. Estimated Demand in the Short Term (2025 Scenario)
    • 12.5.4.3. Estimated Demand in the Long Term (2030 Scenario)
  • 12.6. Vaccines, Global Commercial Demand: Analysis by Number of Patients
  • 12.7. Vaccines, Global Commercial Demand: Analysis by Number of Doses
  • 12.8. Concluding Remarks

13. DEMAND ANALYSIS FOR HUMAN ORGANS

  • 13.1. Chapter Overview
  • 13.2. Scope and Methodology
  • 13.3. Human Organs, Global Demand: Distribution by Geography
    • 13.3.1. Present Demand (2018 Scenario)
    • 13.3.2. Estimated Demand in the Short Term (2025 Scenario)
    • 13.3.3. Estimated Demand in the Long Term (2030 Scenario)
  • 13.3. Human Organs, Global Demand: Analysis by Type of Organ
    • 13.3.1. Kidney
    • 13.3.2. Liver
    • 13.3.3. Heart
    • 13.3.4. Lung
    • 13.3.5. Pancreas and Intestine
  • 13.4. Human Organs, Overall Global Demand
  • 13.5. Concluding Remarks

14. MARKET FORECAST

  • 14.1. Chapter Overview
  • 14.2. Forecast Methodology and Key Assumptions
  • 14.3. Global Cold Chain Logistics Market, 2018-2030
  • 14.4. Global Cold Chain Logistics Market: Distribution by Type of Product
    • 14.4.1. Cold Chain Logistics Market for Cell Therapies, 2018-2030
    • 14.4.2. Cold Chain Logistics Market for Vaccines, 2018-2030
    • 14.4.3. Cold Chain Logistics Market for Human Organs, 2018-2030
  • 14.5. Global Cold Chain Logistics Market: Distribution by Holding Temperature Range
    • 14.5.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030
    • 14.5.2. Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030
    • 14.5.3. Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030
  • 14.6. Global Cold Chain Logistics Market: Distribution by Type of Container
    • 14.6.1. Cold Chain Logistics Market for Active Containers, 2018-2030
    • 14.6.2. Cold Chain Logistics Market for Passive Containers, 2018-2030
  • 14.7. Global Cold Chain Logistics Market: Distribution by Type of End-User
    • 14.7.1. Cold Chain Logistics Market for Industry Players, 2018-2030
    • 14.7.2. Cold Chain Logistics Market for Non-Industry Players, 2018-2030
  • 14.8. Global Cold Chain Logistics Market: Distribution by Geography
    • 14.8.1. Cold Chain Logistics Market in North America, 2018-2030
      • 14.8.1.1. Cold Chain Logistics Market in the US, 2018-2030
      • 14.8.1.2. Cold Chain Logistics Market in Canada, 2018-2030
      • 14.8.1.3. Cold Chain Logistics Market in Mexico, 2018-2030
    • 14.8.2. Cold Chain Logistics Market in Europe, 2018-2030
      • 14.8.2.1. Cold Chain Logistics Market in the UK, 2018-2030
      • 14.8.2.2. Cold Chain Logistics Market in Germany, 2018-2030
      • 14.8.2.3. Cold Chain Logistics Market in France, 2018-2030
      • 14.8.2.4. Cold Chain Logistics Market in Spain, 2018-2030
      • 14.8.2.5. Cold Chain Logistics Market in Italy, 2018-2030
      • 14.8.2.6. Cold Chain Logistics Market in Rest of Europe, 2018-2030
    • 14.8.3. Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030
      • 14.8.3.1. Cold Chain Logistics Market in Australia, 2018-2030
      • 14.8.3.2. Cold Chain Logistics Market in China, 2018-2030
      • 14.8.3.3. Cold Chain Logistics Market in Japan, 2018-2030
      • 14.8.3.4. Cold Chain Logistics Market in India, 2018-2030
      • 14.8.3.5. Cold Chain Logistics Market in Rest of the World, 2018-2030
  • 14.9. Global Cold Chain Logistics Market: Distribution by Type of Product and Geography
    • 14.9.1. Cold Chain Logistics Market for Cell Therapies in North America
      • 14.9.1.1. Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030
      • 14.9.1.2. Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030
      • 14.9.1.3. Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030
    • 14.9.2. Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030
      • 14.9.2.1. Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030
      • 14.9.2.2. Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030
      • 14.9.2.3. Cold Chain Logistics Market for Cell Therapies in France, 2018-2030
      • 14.9.2.4. Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030
      • 14.9.2.5. Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030
      • 14.9.2.6. Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030
    • 14.9.3. Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030
      • 14.9.3.1. Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030
      • 14.9.3.2. Cold Chain Logistics Market for Cell Therapies in China, 2018-2030
      • 14.9.3.3. Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030
      • 14.9.3.4. Cold Chain Logistics Market for Cell Therapies in India, 2018-2030
      • 14.9.3.5. Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030
    • 14.9.4 Cold Chain Logistics Market for Vaccines in North America
      • 14.9.4.1. Cold Chain Logistics Market for Vaccines in the US, 2018-2030
      • 14.9.4.2. Cold Chain Logistics Market for Vaccines in Canada, 2018-2030
      • 14.9.4.3. Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030
    • 14.9.5. Cold Chain Logistics Market for Vaccines in Europe, 2018-2030
      • 14.9.5.1. Cold Chain Logistics Market for Vaccines in the UK, 2018-2030
      • 14.9.5.2. Cold Chain Logistics Market for Vaccines in Germany, 2018-2030
      • 14.9.5.3. Cold Chain Logistics Market for Vaccines in France, 2018-2030
      • 14.9.5.4. Cold Chain Logistics Market for Vaccines in Spain, 2018-2030
      • 14.9.5.5. Cold Chain Logistics Market for Vaccines in Italy, 2018-2030
      • 14.9.5.6. Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030
    • 14.9.6. Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030
      • 14.9.6.1. Cold Chain Logistics Market for Vaccines in Australia, 2018-2030
      • 14.9.6.2. Cold Chain Logistics Market for Vaccines in China, 2018-2030
      • 14.9.6.3. Cold Chain Logistics Market for Vaccines in Japan, 2018-2030
      • 14.9.6.4. Cold Chain Logistics Market for Vaccines in India, 2018-2030
      • 14.9.6.5. Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030
    • 14.9.7. Cold Chain Logistics Market for Human Organs in North America
      • 14.9.7.1. Cold Chain Logistics Market for Human Organs in the US, 2018-2030
      • 14.9.7.2. Cold Chain Logistics Market for Human Organs in Canada, 2018-2030
      • 14.9.7.3. Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030
    • 14.9.8. Cold Chain Logistics Market for Human Organs in Europe, 2018-2030
      • 14.9.8.1. Cold Chain Logistics Market for Human Organs in the UK, 2018-2030
      • 14.9.8.2. Cold Chain Logistics Market for Human Organs in Germany, 2018-2030
      • 14.9.8.3. Cold Chain Logistics Market for Human Organs in France, 2018-2030
      • 14.9.8.4. Cold Chain Logistics Market for Human Organs in Spain, 2018-2030
      • 14.9.8.5. Cold Chain Logistics Market for Human Organs in Italy, 2018-2030
      • 14.9.8.6. Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030
    • 14.9.9. Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030
      • 14.9.9.1. Cold Chain Logistics Market for Human Organs in Australia, 2018-2030
      • 14.9.9.2. Cold Chain Logistics Market for Human Organs in China, 2018-2030
      • 14.9.9.3. Cold Chain Logistics Market for Human Organs in Japan, 2018-2030
      • 14.9.9.4. Cold Chain Logistics Market for Human Organs in India, 2018-2030
      • 14.9.9.5. Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030
  • 14.10. Global Cold Chain Logistics Market: Distribution by Holding Temperature Range and Geography
    • 14.10.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America
      • 14.10.1.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030
      • 14.10.1.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030
      • 14.10.1.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030
    • 14.10.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030
      • 14.10.2.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030
      • 14.10.2.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030
      • 14.10.2.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030
      • 14.10.2.4. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030
      • 14.10.2.5. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030
      • 14.10.2.6. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030
    • 14.10.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030
      • 14.10.3.1. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030
      • 14.10.3.2. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030
      • 14.10.3.3. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030
      • 14.10.3.4. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030
      • 14.10.3.5. Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030
    • 14.10.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America
      • 14.10.4.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030
      • 14.10.4.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030
      • 14.10.4.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030
    • 14.10.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030
      • 14.10.5.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030
      • 14.10.5.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030
      • 14.10.5.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030
      • 14.10.5.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030
      • 14.10.5.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030
      • 14.10.5.6. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030
    • 14.10.6. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030
      • 14.10.6.1. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030
      • 14.10.6.2. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030
      • 14.10.6.3. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030
      • 14.10.6.4. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030
      • 14.10.6.5. Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030
  • 14.11. Global Cold Chain Logistics Market: Distribution by Type of Container and Geography
    • 14.11.1. Cold Chain Logistics Market for Active Containers in North America
      • 14.11.1.1. Cold Chain Logistics Market for Active Containers in the US, 2018-2030
      • 14.11.1.2. Cold Chain Logistics Market for Active Containers in Canada, 2018-2030
      • 14.11.1.3. Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030
    • 14.11.2. Cold Chain Logistics Market for Active Containers in Europe, 2018-2030
      • 14.11.2.1. Cold Chain Logistics Market for Active Containers in the UK, 2018-2030
      • 14.11.2.2. Cold Chain Logistics Market for Active Containers in Germany, 2018-2030
      • 14.11.2.3. Cold Chain Logistics Market for Active Containers in France, 2018-2030
      • 14.11.2.4. Cold Chain Logistics Market for Active Containers in Spain, 2018-2030
      • 14.11.2.5. Cold Chain Logistics Market for Active Containers in Italy, 2018-2030
      • 14.11.2.6. Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030
    • 14.11.3. Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030
      • 14.11.3.1. Cold Chain Logistics Market for Active Containers in Australia, 2018-2030
      • 14.11.3.2. Cold Chain Logistics Market for Active Containers in China, 2018-2030
      • 14.11.3.3. Cold Chain Logistics Market for Active Containers in Japan, 2018-2030
      • 14.11.3.4. Cold Chain Logistics Market for Active Containers in India, 2018-2030
      • 14.11.3.5. Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030
    • 14.11.4. Cold Chain Logistics Market for Passive Containers in North America
      • 14.11.4.1. Cold Chain Logistics Market for Passive Containers in the US, 2018-2030
      • 14.11.4.2. Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030
      • 14.11.4.3. Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030
    • 14.11.5. Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030
      • 14.11.5.1. Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030
      • 14.11.5.2. Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030
      • 14.11.5.3. Cold Chain Logistics Market for Passive Containers in France, 2018-2030
      • 14.11.5.4. Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030
      • 14.11.5.5. Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030
      • 14.11.5.6. Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030
    • 14.11.6. Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030
      • 14.11.6.1. Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030
      • 14.11.6.2. Cold Chain Logistics Market for Passive Containers in China, 2018-2030
      • 14.11.6.3. Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030
      • 14.11.6.4. Cold Chain Logistics Market for Passive Containers in India, 2018-2030
      • 14.11.6.5. Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030
  • 14.12. Global Cold Chain Logistics Market: Distribution by Type of End-User and Geography
    • 14.12.1. Cold Chain Logistics Market for Industry Players in North America
      • 14.12.1.1. Cold Chain Logistics Market for Industry Players in the US, 2018-2030
      • 14.12.1.2. Cold Chain Logistics Market for Industry Players in Canada, 2018-2030
      • 14.12.1.3. Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030
    • 14.12.2. Cold Chain Logistics Market for Industry Players in Europe, 2018-2030
      • 14.12.2.1. Cold Chain Logistics Market for Industry Players in the UK, 2018-2030
      • 14.12.2.2. Cold Chain Logistics Market for Industry Players in Germany, 2018-2030
      • 14.12.2.3. Cold Chain Logistics Market for Industry Players in France, 2018-2030
      • 14.12.2.4. Cold Chain Logistics Market for Industry Players in Spain, 2018-2030
      • 14.12.2.5. Cold Chain Logistics Market for Industry Players in Italy, 2018-2030
      • 14.12.2.6. Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030
    • 14.12.3. Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030
      • 14.12.3.1. Cold Chain Logistics Market for Industry Players in Australia, 2018-2030
      • 14.12.3.2. Cold Chain Logistics Market for Industry Players in China, 2018-2030
      • 14.12.3.3. Cold Chain Logistics Market for Industry Players in Japan, 2018-2030
      • 14.12.3.4. Cold Chain Logistics Market for Industry Players in India, 2018-2030
      • 14.12.3.5. Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030
    • 14.12.4. Cold Chain Logistics Market for Non-Industry Players in North America
      • 14.12.4.1. Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030
      • 14.12.4.2. Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030
      • 14.12.4.3. Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030
    • 14.12.5. Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030
      • 14.12.5.1. Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030
      • 14.12.5.2. Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030
      • 14.12.5.3. Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030
      • 14.12.5.4. Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030
      • 14.12.5.5. Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030
      • 14.12.5.6. Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030
    • 14.12.6. Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030
      • 14.12.6.1. Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030
      • 14.12.6.2. Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030
      • 14.12.6.3. Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030
      • 14.12.6.4. Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030
      • 14.12.6.5. Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030
  • 14.13. Global Cold Chain Logistics Market: Distribution by Type of Product and End-Users
    • 14.13.1. Cold Chain Logistics Market for Cell Therapies for Industry Players
    • 14.13.2. Cold Chain Logistics Market for Cell Therapies for Non-Industry Players
    • 14.13.3. Cold Chain Logistics Market for Vaccines for Industry Players
    • 14.13.4. Cold Chain Logistics Market for Vaccines for Non-Industry Players
    • 14.13.5. Cold Chain Logistics Market for Human Organs for Non-Industry Players
  • 14.14. Concluding Remarks

15. SWOT ANALYSIS

  • 15.1. Chapter Overview
  • 15.2. Strengths
  • 15.3. Weakness
  • 15.4. Opportunities
  • 15.5. Threats
  • 15.6. Comparison of SWOT Factors

16. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

  • 16.1. Chapter Overview
  • 16.2. Connected Cold Chain: Key Tools And Technologies
    • 16.2.1. Artificial Intelligence
    • 16.2.2. Augmented Reality
    • 16.2.3. Automation and Robotics
    • 16.2.4. Big Data Analytics
    • 16.2.5. Blockchain Technology
    • 16.2.6. Cloud Computing
    • 16.2.7. Internet of Things
    • 16.2.8. Radio Frequency Identification (RFID) Tags
  • 16.3. Connected Cold Chain: Future Growth Opportunities
  • 16.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
    • 16.4.1. Methods for Integration of Real-Time Monitoring in Cold Chain Logistics
      • 16.4.1.1. RFID Based Real-Time Monitoring
      • 16.4.1.2. Blockchain and IoT Based Real-Time Monitoring
    • 16.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
    • 16.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain Logistics

17. EXECUTIVE INSIGHTS

  • 17.1. Chapter Overview
  • 17.2. AirBridgeCargo Airlines
    • 17.2.1. Company Snapshot
    • 17.2.2. Interview Transcript: Elena Boykova, Marketing Communications Manager
  • 17.3. Cell and Gene Therapy Catapult
    • 17.3.1. Company Snapshot
    • 17.3.2. Interview Transcript: Jacqueline Barry, Chief Clinical Officer
  • 17.4. UNICEF
    • 17.4.1. Company Snapshot
    • 17.4.2. Interview Transcript: Michelle Arnot-Kruger, Health Specialist, Cold Chain Logistics
  • 17.5. Tabuk Pharmaceuticals
    • 17.5.1. Company Snapshot
    • 17.5.2. Interview Transcript: Shehdeh Abusnineh, Supply Chain Manager

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures:

  • Figure 3.1: Key Steps Involved in Supply Chain
  • Figure 3.2: Differences between Conventional Supply Chain and Cold Chain
  • Figure 3.3: Key Milestones in Cold Chain Logistics Industry
  • Figure 3.4: Applications of Cold Chain Logistics
  • Figure 3.5: Key Components of Cold Chain Logistics Process
  • Figure 3.6: Types of Healthcare Products requiring Cold Chain Logistics
  • Figure 3.7: Recommended Holding Temperature Ranges for Various Healthcare Products
  • Figure 3.8: Types of Active Cold Chain Containers
  • Figure 3.9: Types of Materials / Methods used in Passive Cold Chain Containers
  • Figure 3.10: Types of Insulated Cold Chain Containers
  • Figure 3.11: Key Considerations for Management of Road Shipments
  • Figure 3.12: Key Considerations for Management of Road Shipments using Passive Cold Chain Containers
  • Figure 3.13: Types of Carriers for Air Transportation
  • Figure 3.14: Key Considerations for Management of Air Shipments
  • Figure 3.15: Advantages and Limitations of Cold Chain Logistics in Healthcare
  • Figure 4.1: Key Steps Involved in Cell Therapy Manufacturing and Logistics
  • Figure 4.2: Key Steps Involved in Autologous Cell Therapy Logistics
  • Figure 4.3: Comparison of Cold Chain Logistics Processes for Autologous and Allogeneic Cell Therapies
  • Figure 4.4: Key Considerations for Storage of Cell Therapies
  • Figure 4.5: Key Challenges Related to Cell Therapy Logistics
  • Figure 4.6: Key Considerations for Transportation of Cell Therapies
  • Figure 4.7: Temperature Variations across Cryogenic Vessel / Dewar for Storage of Cell Therapies
  • Figure 4.8: Conditional Recommendations for Process Qualifications for Cell Therapies
  • Figure 4.9: Cell Therapy Logistics Roadmap for the US
  • Figure 4.1 : dvantages of Cellular Orchestration Platforms
  • Figure 4.11: Key Steps in Vaccine Transportation Process
  • Figure 4.12: Key Considerations for Storage of Vaccines
  • Figure 4.13: Heat Sensitivity of Different Types of Vaccines
  • Figure 4.14: Types of Containers for Transportation of Vaccines
  • Figure 4.15: Key Considerations for Storage of Human Organs
  • Figure 4.16: Conventional Methods for Preservation of Human Organs
  • Figure 4.17: Recommended Storage Time Period for Different Human Organs for Maintaining Viability
  • Figure 4.18: Key Considerations for Organ Packaging, Labelling and Transportation
  • Figure 4.19: Logistical Process for Heart-in-a-Box Device
  • Figure 5.1: Cold Chain Logistics Service Providers: Distribution by Year of Establishment
  • Figure 5.2: Cold Chain Logistics Service Providers: Distribution by Location of Headquarters
  • Figure 5.3: Cold Chain Logistics Service Providers: Distribution by Size of Company
  • Figure 5.4: Cold Chain Logistics Service Providers: Distribution by Size of Company and Geographical Location
  • Figure 5.5: Cold Chain Logistics Service Providers: Distribution by Type of Products
  • Figure 5.6: Cold Chain Logistics Service Providers: Distribution by Type of Cold Chain Logistics Services
  • Figure 5.7: Cold Chain Logistics Service Providers: Distribution by Mode of Transportation
  • Figure 5.8: Cold Chain Logistics Service Providers: Distribution by Holding Temperature Range
  • Figure 5.9: Cold Chain Logistics Service Providers: Distribution by Type of Container
  • Figure 5.10: Cold Chain Logistics Service Providers: Distribution by Type of End-User
  • Figure 5.11: Cold Chain Logistics Service Providers: Distribution by Geographical Activity
  • Figure 5.12: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (North America)
  • Figure 5.13: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Europe)
  • Figure 5.14: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Asia-Pacific and Rest of the World)
  • Figure 6.1: Company Competitiveness Analysis: Assumptions and Key Parameters
  • Figure 6.2: Company Competitiveness Analysis: Dot-Plot Representation (Small-sized Players)
  • Figure 6.3: Company Competitiveness Analysis: Dot-Plot Representation (Mid-sized Players)
  • Figure 6.4: Company Competitiveness Analysis: Dot-Plot Representation (Large Players)
  • Figure 7.1: Cryoport: Annual Revenues, 2014-H1 2018 (USD Million)
  • Figure 7.2: Cryoport: Cold Chain Logistics Services / Products
  • Figure 7.3: Lynden International Logistics: Cold Chain Logistics Services / Products
  • Figure 7.4: PAREXEL: Annual Revenues, 2014-2017 (USD Million)
  • Figure 7.5: PAREXEL: Cold Chain Logistics Services / Products
  • Figure 7.6: DHL Express: Annual Revenues, 2014-H1 2018 (EUR Million)
  • Figure 7.7: DHL Express: Cold Chain Logistics Services / Products
  • Figure 7.8: United Parcel Service: Annual Revenues, 2014-H1 2018 (USD Million)
  • Figure 7.9: United Parcel Service: Cold Chain Logistics Services / Products
  • Figure 7.10: GAC: Cold Chain Logistics Services / Products
  • Figure 7.11: Yusen Logistics: Annual Revenues, 2014-H1 2018 (JPY Million)
  • Figure 7.12: Yusen Logistics: Cold Chain Logistics Services / Products
  • Figure 8.1: Partnerships and Collaborations: Cumulative Trend by Year (2014-2018)
  • Figure 8.2: Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3: Partnerships and Collaborations: Cumulative Trend by Type of Partnership and Year (2014-2018)
  • Figure 8.4: Partnerships and Collaborations: Distribution by Type of Product
  • Figure 8.5: Partnerships and Collaborations: Distribution by Type of Cold Chain Logistics Service
  • Figure 8.6: Partnerships and Collaborations: Cumulative Trend by Type of Cold Chain Logistics Service (2014-2018)
  • Figure 8.7: Partnerships and Collaborations: Heat Map Analysis by Type of Cold Chain Logistics Service and Type of Product
  • Figure 8.8: Partnerships and Collaborations: Most Active Players
  • Figure 8.9: Partnerships and Collaborations: Regional Distribution
  • Figure 8.10: Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Figure 8.11: Mergers and Acquisitions: Year-Wise Trend (2014-2018)
  • Figure 8.12: Mergers and Acquisitions: Most Active Acquirers
  • Figure 8.13: Recent Expansions: Capacity Additions (2016-2018)
  • Figure 9.1: Cold Chain Logistics in Healthcare: International and Regional Regulatory Authorities
  • Figure 9.2: WHO Guidelines for Cold Chain Logistics
  • Figure 9.3: IATA (CEIV Pharma) Guidelines for Cold Chain Logistics
  • Figure 9.4: ICH Guidelines for Cold Chain Logistics
  • Figure 9.5: ISTA Guidelines for Cold Chain Logistics
  • Figure 9.6: PDA Guidelines for Cold Chain Logistics
  • Figure 9.7: USFDA Guidelines for Cold Chain Logistics
  • Figure 9.8: USFDA Form483s Excerpts: Challenges and Solutions Related to Cold Chain Logistics
  • Figure 9.9: USP Guidelines for Cold Chain Logistics
  • Figure 9.10: EMA Guidelines for Cold Chain Logistics
  • Figure 9.11: Regulatory Requirements for Various Steps of Cold Chain Logistics
  • Figure 9.12: Comparative Analysis of Regulatory Authorities
  • Figure 10.1: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Year of Approval
  • Figure 10.2: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Type of Molecule and Holding Temperature
  • Figure 10.3: Cold Chain Requirements for Approved Biologics (2014-2018): Analysis by Type of Biologic
  • Figure 10.4: Cold Chain Requirements for Approved Drugs (2014-2018): Heat Map Analysis by Holding Temperature Ranges
  • Figure 10.5: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Dosage Form and Holding Temperature
  • Figure 10.6: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Route of Administration and Holding Temperature
  • Figure 10.7: Cold Chain Requirements for Approved Drugs (2014-2018): Most Active Players
  • Figure 11.1: Cell Therapies, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year
  • Figure 11.2: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy
  • Figure 11.3: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Phase
  • Figure 11.4: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy and Trial Phase
  • Figure 11.5: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Therapeutic Indications
  • Figure 11.6: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Trials (Country-Wise)
  • Figure 11.7: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Trials by Type of Cell Therapy and Trial Phase
  • Figure 11.8: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
  • Figure 11.9: Cell Therapies, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
  • Figure 11.10: Cell Therapies, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
  • Figure 11.11: Cell Therapies, Global Clinical Demand Analysis: Distribution of Enrolled Patient Population by Type of Cell Therapy
  • Figure 11.12: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population (Country-Wise)
  • Figure 11.13: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Type of Cell Therapy and Trial Phase
  • Figure 11.14: Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Number of Product Approvals (2018, 2025 and 2030)
  • Figure 11.15: Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Target Patient Population (2018, 2025 and 2030)
  • Figure 12.1: Vaccines, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year and Holding Temperature Range
  • Figure 12.2: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Holding Temperature Range
  • Figure 12.3: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Phase
  • Figure 12.4: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Status
  • Figure 12.5: Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Trials (Country-Wise)
  • Figure 12.6: Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Trials by Status and Phase
  • Figure 12.7: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
  • Figure 12.8: Vaccines, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
  • Figure 12.9: Vaccines, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
  • Figure 12.10: Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population (Country-Wise)
  • Figure 12.11: Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Holding Temperature and Trial Phase
  • Figure 12.12: Vaccines, Global Commercial Demand Analysis: Distribution by Type of Vaccine
  • Figure 12.13: Mandatory Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Figure 12.14: Mandatory Vaccines, Commercial Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
  • Figure 12.15: Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
  • Figure 12.16: Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
  • Figure 12.17: Optional Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Figure 12.18: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2018 Scenario)
  • Figure 12.19: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
  • Figure 12.20: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
  • Figure 12.21: Vaccines, Global Commercial Demand Analysis: Estimated Demand by Patient Population (2018, 2025 and 2030)
  • Figure 12.22: Vaccines Global Commercial Demand Analysis: Estimated Demand by Number of Doses (2018, 2025 and 2030)
  • Figure 13.1: Human Organs, Global Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Figure 13.2: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
  • Figure 13.3: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2025 Scenario)
  • Figure 13.4: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2030 Scenario)
  • Figure 13.5: Human Organs, Global Demand: Distribution by Type of Organ (2018, 2025 and 2030)
  • Figure 13.6: Global Demand for Kidney: 2018, 2025 and 2030
  • Figure 13.7: Global Demand for Liver: 2018, 2025 and 2030
  • Figure 13.8: Global Demand for Heart: 2018, 2025 and 2030
  • Figure 13.9: Global Demand for Lung: 2018, 2025 and 2030
  • Figure 13.10: Global Demand for Intestine and Pancreas: 2018, 2025 and 2030
  • Figure 13.11: Human Organs, Overall Global Demand: 2018-2030
  • Figure 14.1: Global Cold Chain Logistics Market, 2018-2030: Base Scenario (USD Million)
  • Figure 14.2: Global Cold Chain Logistics Market: Share by Type of Product, 2018 and 2030 (USD Million, %)
  • Figure 14.3: Cold Chain Logistics Market for Cell Therapies, 2018-2030: Base Scenario (USD Million)
  • Figure 14.4: Cold Chain Logistics Market for Vaccines, 2018-2030: Base Scenario (USD Million)
  • Figure 14.5: Cold Chain Logistics Market for Human Organs, 2018-2030: Base Scenario (USD Million)
  • Figure 14.6: Global Cold Chain Logistics Market: Share by Holding Temperature Range, 2018 and 2030 (USD Million, %)
  • Figure 14.7: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030: Base Scenario (USD Million)
  • Figure 14.8: Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030: Base Scenario (USD Million)
  • Figure 14.9: Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030: Base Scenario (USD Million)
  • Figure 14.10: Global Cold Chain Logistics Market: Share by Type of Container, 2018 and 2030 (USD Million, %)
  • Figure 14.11: Cold Chain Logistics Market for Active Containers, 2018-2030: Base Scenario (USD Million)
  • Figure 14.12: Cold Chain Logistics Market for Passive Containers, 2018-2030: Base Scenario (USD Million)
  • Figure 14.13: Global Cold Chain Logistics Market: Share by Type of End-User, 2018 and 2030 (USD Million, %)
  • Figure 14.14: Cold Chain Logistics Market for Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.15: Cold Chain Logistics Market for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.16: Global Cold Chain Logistics Market: Share by Geography, 2018 and 2030 (USD Million, %)
  • Figure 14.17: Cold Chain Logistics Market in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.18: Cold Chain Logistics Market in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.19: Cold Chain Logistics Market in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.20: Cold Chain Logistics Market in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.21: Cold Chain Logistics Market in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.22: Cold Chain Logistics Market in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.23: Cold Chain Logistics Market in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.24: Cold Chain Logistics Market in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.25: Cold Chain Logistics Market in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.26: Cold Chain Logistics Market in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.27: Cold Chain Logistics Market in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.28: Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.29: Cold Chain Logistics Market in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.30: Cold Chain Logistics Market in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.31: Cold Chain Logistics Market in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.32: Cold Chain Logistics Market in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.33: Cold Chain Logistics Market in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.34: Cold Chain Logistics Market for Cell Therapies in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.35: Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.36: Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.37: Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.38: Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.39: Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.40: Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.41: Cold Chain Logistics Market for Cell Therapies in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.42: Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.43: Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.44: Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.45: Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.46: Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.47: Cold Chain Logistics Market for Cell Therapies in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.48: Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.49: Cold Chain Logistics Market for Cell Therapies in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.50: Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.51: Cold Chain Logistics Market for Vaccines in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.52: Cold Chain Logistics Market for Vaccines in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.53: Cold Chain Logistics Market for Vaccines in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.54: Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.55: Cold Chain Logistics Market for Vaccines in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.56: Cold Chain Logistics Market for Vaccines in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.57: Cold Chain Logistics Market for Vaccines in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.58: Cold Chain Logistics Market for Vaccines in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.59: Cold Chain Logistics Market for Vaccines in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.60: Cold Chain Logistics Market for Vaccines in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.61: Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.62: Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.63: Cold Chain Logistics Market for Vaccines in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.64: Cold Chain Logistics Market for Vaccines in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.65: Cold Chain Logistics Market for Vaccines in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.66: Cold Chain Logistics Market for Vaccines in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.67: Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.68: Cold Chain Logistics Market for Human Organs in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.69: Cold Chain Logistics Market for Human Organs in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.70: Cold Chain Logistics Market for Human Organs in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.71: Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.72: Cold Chain Logistics Market for Human Organs in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.73: Cold Chain Logistics Market for Human Organs in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.74: Cold Chain Logistics Market for Human Organs in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.75: Cold Chain Logistics Market for Human Organs in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.76: Cold Chain Logistics Market for Human Organs in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.77: Cold Chain Logistics Market for Human Organs in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.78: Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.79: Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.80: Cold Chain Logistics Market for Human Organs in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.81: Cold Chain Logistics Market for Human Organs in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.82: Cold Chain Logistics Market for Human Organs in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.83: Cold Chain Logistics Market for Human Organs in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.84: Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.85: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.86: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.87: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.88: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.89: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.90: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.91: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.92: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.93: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.94: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.95: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.96: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.97: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.98: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.99: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.100: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.101: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.102: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.103: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.104: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.105: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.106: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.107: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.108: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.109: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.110: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.111: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.112: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.113: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.114: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.115: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.116: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.117: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.118: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.119: Cold Chain Logistics Market for Active Containers in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.120: Cold Chain Logistics Market for Active Containers in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.121: Cold Chain Logistics Market for Active Containers in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.122: Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.123: Cold Chain Logistics Market for Active Containers in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.124: Cold Chain Logistics Market for Active Containers in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.125: Cold Chain Logistics Market for Active Containers in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.126: Cold Chain Logistics Market for Active Containers in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.127: Cold Chain Logistics Market for Active Containers in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.128: Cold Chain Logistics Market for Active Containers in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.129: Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.130: Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.131: Cold Chain Logistics Market for Active Containers in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.132: Cold Chain Logistics Market for Active Containers in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.133: Cold Chain Logistics Market for Active Containers in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.134: Cold Chain Logistics Market for Active Containers in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.135: Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.136: Cold Chain Logistics Market for Passive Containers in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.137: Cold Chain Logistics Market for Passive Containers in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.138: Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.139: Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.140: Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.141: Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.142: Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.143: Cold Chain Logistics Market for Passive Containers in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.144: Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.145: Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.146: Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.147: Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.148: Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.149: Cold Chain Logistics Market for Passive Containers in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.150: Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.151: Cold Chain Logistics Market for Passive Containers in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.152: Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.153: Cold Chain Logistics Market for Industry Players in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.154: Cold Chain Logistics Market for Industry Players in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.155: Cold Chain Logistics Market for Industry Players in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.156: Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.157: Cold Chain Logistics Market for Industry Players in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.158: Cold Chain Logistics Market for Industry Players in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.159: Cold Chain Logistics Market for Industry Players in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.160: Cold Chain Logistics Market for Industry Players in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.161: Cold Chain Logistics Market for Industry Players in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.162: Cold Chain Logistics Market for Industry Players in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.163: Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.164: Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.165: Cold Chain Logistics Market for Industry Players in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.166: Cold Chain Logistics Market for Industry Players in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.167: Cold Chain Logistics Market for Industry Players in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.168: Cold Chain Logistics Market for Industry Players in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.169: Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.170: Cold Chain Logistics Market for Non-Industry Players in North America, 2018-2030: Base Scenario (USD Million)
  • Figure 14.171: Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030: Base Scenario (USD Million)
  • Figure 14.172: Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030: Base Scenario (USD Million)
  • Figure 14.173: Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030: Base Scenario (USD Million)
  • Figure 14.174: Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.175: Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030: Base Scenario (USD Million)
  • Figure 14.176: Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030: Base Scenario (USD Million)
  • Figure 14.177: Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030: Base Scenario (USD Million)
  • Figure 14.178: Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030: Base Scenario (USD Million)
  • Figure 14.179: Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030: Base Scenario (USD Million)
  • Figure 14.180: Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030: Base Scenario (USD Million)
  • Figure 14.181: Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.182: Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030: Base Scenario (USD Million)
  • Figure 14.183: Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030: Base Scenario (USD Million)
  • Figure 14.184: Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030: Base Scenario (USD Million)
  • Figure 14.185: Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030: Base Scenario (USD Million)
  • Figure 14.186: Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030: Base Scenario (USD Million)
  • Figure 14.187: Global Cold Chain Logistics Market for Cell Therapies for Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.188: Global Cold Chain Logistics Market for Cell Therapies for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.189: Global Cold Chain Logistics Market for Vaccines for Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.190: Global Cold Chain Logistics Market for Vaccines for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.191: Global Cold Chain Logistics Market for Human Organs for Non-Industry Players, 2018-2030: Base Scenario (USD Million)
  • Figure 14.192: Global Cold Chain Logistics Market, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Figure 15.1: Cold Chain Management in Healthcare: SWOT Analysis
  • Figure 15.2: Comparison of SWOT Factors: Harvey Ball Analysis
  • Figure 16.1: Connected Cold Chain Solutions: Process Flow Diagram
  • Figure 16.2: Artificial Intelligence in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.3: Augmented Reality in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.4: Automation and Robotics in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.5: Big Data Analytics in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.6: Blockchain Technology in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.7: Cloud Computing in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.8: Internet of Things in Cold Chain Logistics: Schematic Representation
  • Figure 16.9: Internet of Things in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.10: RFID in Cold Chain Logistics: Key Benefits and Challenges
  • Figure 16.11: Connected Cold Chain: Future Growth Opportunities (Harvey Ball Analysis)
  • Figure 16.12: Real-Time Monitoring: Conventional Devices
  • Figure 16.13: RFID Based Real-Time Monitoring in Cold Chain Logistics
  • Figure 16.14: Key Contributions of Blockchain Technology and IoT in Real-Time Monitoring
  • Figure 16.15: Blockchain Technology and IoT Based Real-Time Monitoring: Flow Diagram
  • Figure 16.16: Real-Time Monitoring in Cold Chain Management: Growth Opportunities
  • Figure 16.17: Real-Time Monitoring: Reduction in Cold Chain Logistics Cost

List of Tables:

  • Table 3.1: Comparison of Different Modes of Transportation
  • Table 4.1: Assessment Strategies for Cell Therapies
  • Table 4.2: Potential Strategies to Overcome Existing Challenges in Cell Therapy Logistics
  • Table 4.3: Classification of Vaccines based on Method of Development
  • Table 4.4: Recommended Holding Temperature Ranges for Different Type of Vaccines
  • Table 4.5: Logistics Complexity Analysis
  • Table 5.1: Cold Chain Logistics Service Providers: List of Industry Players
  • Table 5.2: Cold Chain Logistics Service Providers: Details on Type of Products
  • Table 5.3: Cold Chain Logistics Service Providers: Details on Services Offered
  • Table 5.4: Cold Chain Logistics Service Providers: Details on Mode of Transportation
  • Table 5.5: Cold Chain Logistics Service Providers: Details on Holding Temperature Range
  • Table 5.6: Cold Chain Logistics Service Providers: Details on Type of Container
  • Table 5.7: Cold Chain Logistics Service Providers: Details on Type of End-User
  • Table 5.8: Cold Chain Logistics Service Providers: Details on Geographical Activity
  • Table 5.9: Cold Chain Logistics Service Providers: Details on Location of Cold Chain Facility
  • Table 5.10: List of Cold Chain Logistics Service Providers for Other Healthcare Products
  • Table 5.11: List of Equipment / Technologies for Cold Chain Logistics
  • Table 6.1: Company Competitive Analysis: Small-sized Players
  • Table 6.2: Company Competitive Analysis: Mid-sized Players
  • Table 6.3: Company Competitive Analysis: Large Players
  • Table 7.1: Cold Chain Logistics Service Providers: List of Companies Profiled
  • Table 7.2: Cryoport: Key Highlights
  • Table 7.3: Cryoport: Recent Partnerships
  • Table 7.4: Cryoport: Future Outlook
  • Table 7.5: Lynden International Logistics: Key Highlights
  • Table 7.6: Lynden International Logistics: Future Outlook
  • Table 7.7: PAREXEL: Key Highlights
  • Table 7.8: PAREXEL: Future Outlook
  • Table 7.9: DHL Express: Key Highlights
  • Table 7.10: DHL Express: Recent Partnerships
  • Table 7.11: DHL Express: Future Outlook
  • Table 7.12: United Parcel Service: Key Highlights
  • Table 7.13: United Parcel Service: Recent Partnerships
  • Table 7.14: United Parcel Service: Future Outlook
  • Table 7.15: GAC: Key Highlights
  • Table 7.16: GAC: Future Outlook
  • Table 7.17: Yusen Logistics: Key Highlights
  • Table 7.18: Yusen Logistics: Recent Partnerships
  • Table 7.19: Yusen Logistics: Future Outlook
  • Table 8.1: Cold Chain Logistics in Healthcare: Partnerships and Collaborations, 2014-2018
  • Table 8.2: Cold Chain Logistics in Healthcare: List of Recent Expansions (2016-2018)
  • Table 10.1: List of USFDA Approved Drugs: Cold Chain Requirements (2014-2018)
  • Table 16.1: Artificial Intelligence in Cold Chain Logistics: List of Companies
  • Table 16.2: Automation and Robotics in Cold Chain Logistics: List of Companies
  • Table 16.3: Big Data Analytics in Cold Chain Logistics: List of Companies
  • Table 16.4: Blockchain Technology in Cold Chain Logistics: List of Companies
  • Table 16.5: Cloud Computing in Cold Chain Logistics: List of Companies
  • Table 16.6: Internet of Things in Cold Chain Logistics: List of Companies
  • Table 16.7: RFID Tags in Cold Chain Logistics: List of Companies
  • Table 17.1: AirBridgeCargo Airlines: Key Highlights
  • Table 17.2: Cell and Gene Therapy Catapult: Key Highlights
  • Table 17.3: UNICEF: Key Highlights
  • Table 17.4: Tabuk Pharmaceuticals: Key Highlights
  • Table 18.1: Cold Chain Logistics Service Providers: Distribution by Year of Establishment
  • Table 18.2: Cold Chain Logistics Service Providers: Distribution by Location of Headquarters
  • Table 18.3: Cold Chain Logistics Service Providers: Distribution by Size of Company
  • Table 18.4: Cold Chain Logistics Service Providers: Distribution by Size of Company and Geographical Location
  • Table 18.5: Cold Chain Logistics Service Providers: Distribution by Type of Products
  • Table 18.6: Cold Chain Logistics Service Providers: Distribution by Type of Cold Chain Logistics Services
  • Table 18.7: Cold Chain Logistics Service Providers: Distribution by Mode of Transportation
  • Table 18.8: Cold Chain Logistics Service Providers: Distribution by Holding Temperature Range
  • Table 18.9: Cold Chain Logistics Service Providers: Distribution by Type of Container
  • Table 18.10: Cold Chain Logistics Service Providers: Distribution by Type of End-User
  • Table 18.11: Cold Chain Logistics Service Providers: Distribution by Geographical Activity
  • Table 18.12: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (North America)
  • Table 18.13: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Europe)
  • Table 18.14: Cold Chain Logistics Service Providers: Distribution by Location of Cold Chain Facility (Asia-Pacific and Rest of the World)
  • Table 18.15: Cryoport: Annual Revenues, 2014-H1 2018 (USD Million)
  • Table 18.16: PAREXEL: Annual Revenues, 2014-2017 (USD Million)
  • Table 18.17: DHL Express: Annual Revenues, 2014-H1 2018 (EUR Million)
  • Table 18.18: United Parcel Service: Annual Revenues, 2014-H1 2018 (USD Million)
  • Table 18.19: Yusen Logistics: Annual Revenues, 2014-H1 2018 (JPY Million)
  • Table 18.20: Partnerships and Collaborations: Cumulative Trend by Year (2014-2018)
  • Table 18.21: Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 18.22: Partnerships and Collaborations: Cumulative Trend by Type of Partnership and Year (2014-2018)
  • Table 18.23: Partnerships and Collaborations: Distribution by Type of Product
  • Table 18.24: Partnerships and Collaborations: Distribution by Type of Cold Chain Logistics Service
  • Table 18.25: Partnerships and Collaborations: Cumulative Trend by Type of Cold Chain Logistics Service
  • Table 18.26: Partnerships and Collaborations: Most Active Players
  • Table 18.27: Partnerships and Collaborations: Regional Distribution
  • Table 18.28: Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Table 18.29: Mergers and Acquisitions: Most Active Acquirers
  • Table 18.30: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Year of Approval
  • Table 18.31: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Type of Molecule and Holding Temperature
  • Table 18.32: Cold Chain Requirements for Approved Biologics (2014-2018): Analysis by Type of Biologic
  • Table 18.33: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Dosage Form and Holding Temperature
  • Table 18.34: Cold Chain Requirements for Approved Drugs (2014-2018): Analysis by Route of Administration and Holding Temperature
  • Table 18.35: Cold Chain Requirements for Approved Drugs (2014-2018): Most Active Players
  • Table 18.36: Cell Therapies, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year
  • Table 18.37: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy
  • Table 18.38: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Trial Phase
  • Table 18.39: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Cell Therapy and Trial Phase
  • Table 18.40: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Therapeutic Indications
  • Table 18.41: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Number of Trials (Country-Wise)
  • Table 18.42: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Type of Cell Therapy and Trial Phase
  • Table 18.43: Cell Therapies, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
  • Table 18.44: Cell Therapies, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
  • Table 18.45: Cell Therapies, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
  • Table 18.46: Cell Therapies, Global Clinical Demand Analysis: Distribution of Enrolled Patient Population by Type of Cell Therapy
  • Table 18.47: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution by Enrolled Patient Population (Country-Wise)
  • Table 18.48: Cell Therapies, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Type of Cell Therapy and Trial Phase
  • Table 18.49: Cell Therapies, Global Commercial Demand Analysis: Estimated Demand by Number of Product Approvals (2018, 2025 and 2030)
  • Table 18.50: Cell Therapies, Global Commercial Demand: Estimated Demand by Target Patient Population (2018, 2025 and 2030)
  • Table 18.51: Vaccines, Global Clinical Demand Analysis: Cumulative Distribution of Trials by Registration Year and Holding Temperature Range
  • Table 18.52: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Holding Temperature Range
  • Table 18.53: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Trial Phase
  • Table 18.54: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Trial Status
  • Table 18.55: Vaccines, Global Clinical Demand Analysis: Geographical Distribution by Number of Trials (Country-Wise)
  • Table 18.56: Vaccines, Global Clinical Demand Analysis: Geographical Distribution by Trial Status and Trial Phase
  • Table 18.57: Vaccines, Global Clinical Demand Analysis: Distribution of Trials by Type of Sponsors / Collaborators
  • Table 18.58: Vaccines, Global Clinical Demand Analysis: Most Active Industry Players in Terms of Number of Trials Conducted
  • Table 18.59: Vaccines, Global Clinical Demand Analysis: Most Active Non-Industry Players in Terms of Number of Trials Conducted
  • Table 18.60: Vaccines Global Clinical Demand Analysis: Geographical Distribution by Enrolled Patient Population (Country-Wise)
  • Table 18.61: Vaccines, Global Clinical Demand Analysis: Geographical Distribution of Enrolled Patient Population by Holding Temperature and Trial Phase
  • Table 18.62: Vaccines, Global Commercial Demand Analysis: Distribution by Type of Vaccine
  • Table 18.63: Mandatory Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Table 18.64: Mandatory Vaccines, Commercial Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
  • Table 18.65: Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
  • Table 18.66: Mandatory Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
  • Table 18.67: Optional Vaccines, Global Commercial Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Table 18.68: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2018 Scenario)
  • Table 18.69: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2025 Scenario)
  • Table 18.70: Optional Vaccines, Commercial Demand Analysis : Distribution by Geography (Country-Wise, 2030 Scenario)
  • Table 18.71: Vaccines, Global Commercial Demand Analysis: Estimated Demand by Patient Population (2018, 2025 and 2030)
  • Table 18.72: Vaccines Global Commercial Demand Analysis: Estimated Demand by Number of Doses (2018, 2025 and 2030)
  • Table 18.73: Human Organs, Global Demand Analysis: Distribution by Geography (2018, 2025 and 2030)
  • Table 18.74: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2018 Scenario)
  • Table 18.75: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2025 Scenario)
  • Table 18.76: Human Organs, Global Demand Analysis: Distribution by Geography (Country-Wise, 2030 Scenario)
  • Table 18.77: Human Organs, Global Demand: Distribution by Type of Organ (2018, 2025 and 2030)
  • Table 18.78: Global Demand for Kidney: 2018, 2025 and 2030
  • Table 18.79: Global Demand for Liver: 2018, 2025 and 2030
  • Table 18.80: Global Demand for Heart: 2018, 2025 and 2030
  • Table 18.81: Global Demand for Lung: 2018, 2025 and 2030
  • Table 18.82: Global Demand for Intestine and Pancreas: 2018, 2025 and 2030
  • Table 18.83: Human Organs, Overall Global Demand: 2018-2030
  • Table 18.84: Global Cold Chain Logistics Market, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.85: Global Cold Chain Logistics Market: Share by Type of Product, 2018 and 2030 (USD Million, %)
  • Table 18.86: Cold Chain Logistics Market for Cell Therapies, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.87: Cold Chain Logistics Market for Vaccines, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.88: Cold Chain Logistics Market for Human Organs, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.89: Global Cold Chain Logistics Market: Share by Holding Temperature Range, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
  • Table 18.90: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.91: Cold Chain Logistics Market for Products Requiring Frozen Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.92: Cold Chain Logistics Market for Products Requiring Cryogenic Temperature, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.93: Global Cold Chain Logistics Market: Share by Type of Container, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
  • Table 18.94: Cold Chain Logistics Market for Active Containers, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.95: Cold Chain Logistics Market for Passive Containers, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.96: Global Cold Chain Logistics Market: Share by Type of End-User, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
  • Table 18.97: Cold Chain Logistics Market for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.98: Cold Chain Logistics Market for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.99: Global Cold Chain Logistics Market: Share by Geography, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million, %)
  • Table 18.100: Cold Chain Logistics Market in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.101: Cold Chain Logistics Market in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.102: Cold Chain Logistics Market in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.103: Cold Chain Logistics Market in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.104: Cold Chain Logistics Market in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.105: Cold Chain Logistics Market in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.106: Cold Chain Logistics Market in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.107: Cold Chain Logistics Market in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.108: Cold Chain Logistics Market in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.109: Cold Chain Logistics Market in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.110: Cold Chain Logistics Market in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.111: Cold Chain Logistics Market in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.112: Cold Chain Logistics Market in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.113: Cold Chain Logistics Market in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.114: Cold Chain Logistics Market in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.115: Cold Chain Logistics Market in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.116: Cold Chain Logistics Market in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.117: Cold Chain Logistics Market for Cell Therapies in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.118: Cold Chain Logistics Market for Cell Therapies in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.119: Cold Chain Logistics Market for Cell Therapies in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.120: Cold Chain Logistics Market for Cell Therapies in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.121: Cold Chain Logistics Market for Cell Therapies in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.122: Cold Chain Logistics Market for Cell Therapies in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.123: Cold Chain Logistics Market for Cell Therapies in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.124: Cold Chain Logistics Market for Cell Therapies in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.125: Cold Chain Logistics Market for Cell Therapies in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.126: Cold Chain Logistics Market for Cell Therapies in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.127: Cold Chain Logistics Market for Cell Therapies in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.128: Cold Chain Logistics Market for Cell Therapies in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.129: Cold Chain Logistics Market for Cell Therapies in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.130: Cold Chain Logistics Market for Cell Therapies in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.131: Cold Chain Logistics Market for Cell Therapies in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.132: Cold Chain Logistics Market for Cell Therapies in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.133: Cold Chain Logistics Market for Cell Therapies in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.134: Cold Chain Logistics Market for Vaccines in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.135: Cold Chain Logistics Market for Vaccines in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.136: Cold Chain Logistics Market for Vaccines in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.137: Cold Chain Logistics Market for Vaccines in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.138: Cold Chain Logistics Market for Vaccines in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.139: Cold Chain Logistics Market for Vaccines in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.140: Cold Chain Logistics Market for Vaccines in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.141: Cold Chain Logistics Market for Vaccines in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.142: Cold Chain Logistics Market for Vaccines in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.143: Cold Chain Logistics Market for Vaccines in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.144: Cold Chain Logistics Market for Vaccines in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.145: Cold Chain Logistics Market for Vaccines in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.146: Cold Chain Logistics Market for Vaccines in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.147: Cold Chain Logistics Market for Vaccines in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.148: Cold Chain Logistics Market for Vaccines in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.149: Cold Chain Logistics Market for Vaccines in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.150: Cold Chain Logistics Market for Vaccines in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.151: Cold Chain Logistics Market for Human Organs in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.152: Cold Chain Logistics Market for Human Organs in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.153: Cold Chain Logistics Market for Human Organs in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.154: Cold Chain Logistics Market for Human Organs in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.155: Cold Chain Logistics Market for Human Organs in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.156: Cold Chain Logistics Market for Human Organs in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.157: Cold Chain Logistics Market for Human Organs in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.158: Cold Chain Logistics Market for Human Organs in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.159: Cold Chain Logistics Market for Human Organs in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.160: Cold Chain Logistics Market for Human Organs in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.161: Cold Chain Logistics Market for Human Organs in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.162: Cold Chain Logistics Market for Human Organs in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.163: Cold Chain Logistics Market for Human Organs in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.164: Cold Chain Logistics Market for Human Organs in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.165: Cold Chain Logistics Market for Human Organs in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.166: Cold Chain Logistics Market for Human Organs in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.167: Cold Chain Logistics Market for Human Organs in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.168: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.169: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.170: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.171: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.172: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.173: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.174: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.175: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.176: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.177: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.178: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.179: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.180: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.181: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.182: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.183: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.184: Cold Chain Logistics Market for Products Requiring Refrigerated Temperature in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.185: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.186: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.187: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.188: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.189: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.190: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.191: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.192: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.193: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.194: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.195: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.196: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.197: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.198: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.199: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.200: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.201: Cold Chain Logistics Market for Products Requiring Frozen and Cryogenic Temperature in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.202: Cold Chain Logistics Market for Active Containers in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.203: Cold Chain Logistics Market for Active Containers in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.204: Cold Chain Logistics Market for Active Containers in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.205: Cold Chain Logistics Market for Active Containers in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.206: Cold Chain Logistics Market for Active Containers in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.207: Cold Chain Logistics Market for Active Containers in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.208: Cold Chain Logistics Market for Active Containers in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.209: Cold Chain Logistics Market for Active Containers in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.210: Cold Chain Logistics Market for Active Containers in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.211: Cold Chain Logistics Market for Active Containers in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.212: Cold Chain Logistics Market for Active Containers in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.213: Cold Chain Logistics Market for Active Containers in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.214: Cold Chain Logistics Market for Active Containers in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.215: Cold Chain Logistics Market for Active Containers in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.216: Cold Chain Logistics Market for Active Containers in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.217: Cold Chain Logistics Market for Active Containers in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.218: Cold Chain Logistics Market for Active Containers in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.219: Cold Chain Logistics Market for Passive Containers in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.220: Cold Chain Logistics Market for Passive Containers in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.221: Cold Chain Logistics Market for Passive Containers in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.222: Cold Chain Logistics Market for Passive Containers in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.223: Cold Chain Logistics Market for Passive Containers in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.224: Cold Chain Logistics Market for Passive Containers in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.225: Cold Chain Logistics Market for Passive Containers in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.226: Cold Chain Logistics Market for Passive Containers in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.227: Cold Chain Logistics Market for Passive Containers in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.228: Cold Chain Logistics Market for Passive Containers in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.229: Cold Chain Logistics Market for Passive Containers in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.230: Cold Chain Logistics Market for Passive Containers in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.231: Cold Chain Logistics Market for Passive Containers in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.232: Cold Chain Logistics Market for Passive Containers in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.233: Cold Chain Logistics Market for Passive Containers in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.234: Cold Chain Logistics Market for Passive Containers in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.235: Cold Chain Logistics Market for Passive Containers in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.236: Cold Chain Logistics Market for Industry Players in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.237: Cold Chain Logistics Market for Industry Players in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.238: Cold Chain Logistics Market for Industry Players in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.239: Cold Chain Logistics Market for Industry Players in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.240: Cold Chain Logistics Market for Industry Players in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.241: Cold Chain Logistics Market for Industry Players in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.242: Cold Chain Logistics Market for Industry Players in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.243: Cold Chain Logistics Market for Industry Players in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.244: Cold Chain Logistics Market for Industry Players in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.245: Cold Chain Logistics Market for Industry Players in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.246: Cold Chain Logistics Market for Industry Players in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.247: Cold Chain Logistics Market for Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.248: Cold Chain Logistics Market for Industry Players in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.249: Cold Chain Logistics Market for Industry Players in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.250: Cold Chain Logistics Market for Industry Players in Japan, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.251: Cold Chain Logistics Market for Industry Players in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.252: Cold Chain Logistics Market for Industry Players in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.253: Cold Chain Logistics Market for Non-Industry Players in North America, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.254: Cold Chain Logistics Market for Non-Industry Players in the US, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.255: Cold Chain Logistics Market for Non-Industry Players in Canada, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.256: Cold Chain Logistics Market for Non-Industry Players in Mexico, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.257: Cold Chain Logistics Market for Non-Industry Players in Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.258: Cold Chain Logistics Market for Non-Industry Players in the UK, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.259: Cold Chain Logistics Market for Non-Industry Players in Germany, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.260: Cold Chain Logistics Market for Non-Industry Players in France, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.261: Cold Chain Logistics Market for Non-Industry Players in Spain, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.262: Cold Chain Logistics Market for Non-Industry Players in Italy, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.263: Cold Chain Logistics Market for Non-Industry Players in Rest of Europe, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.264: Cold Chain Logistics Market for Non-Industry Players in Asia-Pacific and Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.265: Cold Chain Logistics Market for Non-Industry Players in Australia, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.266: Cold Chain Logistics Market for Non-Industry Players in China, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.267: Cold Chain Logistics Market for Non-Industry Players in Japan, 2018-2030 (USD Million) : Conservative, Base and Optimistic Scenarios
  • Table 18.268: Cold Chain Logistics Market for Non-Industry Players in India, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.269: Cold Chain Logistics Market for Non-Industry Players in Rest of the World, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.270: Global Cold Chain Logistics Market for Cell Therapies for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.271: Global Cold Chain Logistics Market for Cell Therapies for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.272: Global Cold Chain Logistics Market for Vaccines for Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.273: Global Cold Chain Logistics Market for Vaccines for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.274: Global Cold Chain Logistics Market for Human Organs for Non-Industry Players, 2018-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 18.275: Global Cold Chain Logistics Market, 2018 and 2030: Conservative, Base and Optimistic Scenarios (USD Million)

Listed Companies:

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1. 1st Response Medical Services
  • 2. 5NINES
  • 3. AB Oxford Cold Storage
  • 4. A+P Grupo
  • 5. AbbVie
  • 6. Abu Dhabi Medical Devices
  • 7. ACADIA Pharmaceuticals
  • 8. Accelogix
  • 9. Accucold
  • 10. Accuristix
  • 11. Achaogen
  • 12. Actelion Pharmaceuticals
  • 13. Adaptimmune Therapeutics
  • 14. Advanced Accelerator Applications
  • 15. Advantage Parcel Express (Apex)
  • 16. Aerie Pharmaceuticals
  • 17. AeroCare Medical Transport System
  • 18. AeroSafe Global
  • 19. Agility Logistics
  • 20. Agios Pharmaceuticals
  • 21. AI Shifa Medical Syringes
  • 22. Air Canada Cargo
  • 23. Air France KLM Martinair Cargo
  • 24. Air Liquide
  • 25. AirBridgeCargo Airlines
  • 26. Airmax
  • 27. Airmedic
  • 28. AIT Worldwide Logistics
  • 29. AkaRx
  • 30. Alba Smart Automation
  • 31. Alcon Laboratories
  • 32. Alexion Pharmaceuticals
  • 33. Alia MedFlight
  • 34. Alibaba Group
  • 35. Alkermes
  • 36. Allergan
  • 37. Almac Group
  • 38. Alpine Air Ambulance
  • 39. Ambetronics Engineers
  • 40. American Airlines Cargo
  • 41. American Society of Gene and Cell Therapy
  • 42. AmerisourceBergen
  • 43. Amgen
  • 44. Amson Vaccines & Pharma
  • 45. Anacor Pharmaceuticals
  • 46. Anhui Tiankang Medical Technology
  • 47. AntTail
  • 48. Anwood Logistics Systems
  • 49. AOV International
  • 50. Apex International
  • 51. American President Lines
  • 52. Aqua Logistics
  • 53. Aramex
  • 54. Arcticold Logistics
  • 55. ARIAD Pharmaceuticals
  • 56. Array BioPharma
  • 57. Assa Abloy
  • 58. AssetTrackr
  • 59. Astellas Pharma
  • 60. AstraZeneca
  • 61. Atelerix
  • 62. dnstruments
  • 63. AUCMA
  • 64. Aviators Air Rescue
  • 65. B Medical Systems
  • 66. Bachem
  • 67. Badu (Xiamen) Technology
  • 68. Balaji Distributors
  • 69. Bausch & Lomb
  • 70. Bayer
  • 71. Baylor College of Medicine
  • 72. Be The Match BioTherapies
  • 73. Becton Dickinson
  • 74. Belglobe
  • 75. Bennett International Group
  • 76. Berlinger
  • 77. Beyond Wireless Technology
  • 78. Bio Pharma Logistics
  • 79. Biocair
  • 80. BioCision
  • 81. BioCryst Pharmaceuticals
  • 82. Biogen
  • 83. BioLife Solutions
  • 84. BioMarin Pharmaceutical
  • 85. BioSpeciMan
  • 86. Biostor Ireland
  • 87. BioStorage Technologies
  • 88. Biotec Services International
  • 89. Biotech & Pharma Logistics
  • 90. Blackcoffer
  • 91. Bloodworks Northwest
  • 92. Blowkings
  • 93. Blue Earth
  • 94. Bluechiip
  • 95. BluLine Solutions
  • 96. Boehringer Ingelheim
  • 97. Bollore Logistics
  • 98. Boston Biomedical
  • 99. Boxcold Logistics
  • 100. Bracco Diagnostics
  • 101. Brigham and Women's Hospital
  • 102. Bristol-Myers Squibb
  • 103. Broekman Logistics
  • 104. Brooks Life Sciences
  • 105. Burris Logistics
  • 106. CA Transport
  • 107. CAL Cargo Airlines
  • 108. Camio Logisticss
  • 109. Cardinal Health
  • 110. CargoSense
  • 111. Catalent
  • 112. Cell and Gene Therapy Catapult
  • 113. Centers for Disease Control and Prevention
  • 114. Cause Analytics
  • 115. Cavalier Logistics
  • 116. Celgene
  • 117. Centrofarm
  • 118. CEVA Logistics
  • 119. Chain.io
  • 120. Channel Freight Services
  • 121. Chart Industries
  • 122. Chase Doors
  • 123. Chelsea Therapeutics
  • 124. Chemo Research
  • 125. Chengdu Xinjin Shifeng Medical Apparatus & Instrument
  • 126. Chiesi USA
  • 127. Chilled Logistics
  • 128. Chiltern Cold Storage Group
  • 129. Chimera Biotec
  • 130. CHS Air Logistics
  • 131. City Xpress Delivery
  • 132. Cleveland Cord Blood Center
  • 133. ClinImmune Labs
  • 134. Clovis Oncology
  • 135. Coastal Pacific Xpress
  • 136. Cold Box Express
  • 137. Cold Chain IQ
  • 138. Cold Chain Technologies
  • 139. ColdEX Logistics
  • 140. CombiMatrix
  • 141. Comprehensive Care
  • 142. Continental Cargo
  • 143. Conveyor Uni Express
  • 144. Cool Lab
  • 145. CoolPac
  • 146. Cooltrax
  • 147. Corex
  • 148. Critical Path
  • 149. Cryo Express
  • 150. Cryo Store
  • 151. Cryopak
  • 152. Cryoport
  • 153. Crystal Logistic Cool Chain
  • 154. CSafe Global
  • 155. CSM
  • 156. CTI Cold Chain
  • 157. Cubist Pharmaceuticals
  • 158. Carlson Wagonlit Travel
  • 159. CyberFreight
  • 160. Daiichi Sankyo
  • 161. Dana-Farber Cancer Institute
  • 162. DB Schenker
  • 163. Deliver Plus
  • 164. Delta Cargo
  • 165. Delta UK Express
  • 166. DeltaTrak
  • 167. Dendreon
  • 168. DHL Express
  • 169. Diamond Couriers
  • 170. Digital Supply Chain Institute
  • 171. DilinxRFID
  • 172. DiscGenics
  • 173. Dooile
  • 174. DSV
  • 175. Duke University School of Medicine
  • 176. Dulas
  • 177. DuPont
  • 178. Durata Therapeutics
  • 179. Dynamox
  • 180. Eisai
  • 181. Eli Lilly
  • 182. Elitech
  • 183. ELPRO-BUCHS
  • 184. Elusys Therapeutics
  • 185. EMD Serono
  • 186. Emergent Cold
  • 187. ENLAKE
  • 188. Enterra Solutions
  • 189. Envirotainer
  • 190. EPx Logistics
  • 191. Escort Cold Chain Solutions
  • 192. Ethiopian Airlines
  • 193. European Air Ambulance
  • 194. Eurosoft Systems
  • 195. EVARA
  • 196. EXAM Transport
  • 197. Exel
  • 198. Expeditors
  • 199. Exusia
  • 200. FactR Pay
  • 201. FarEye
  • 202. FedEx
  • 203. Ferrer
  • 204. Fibrocell Technologies
  • 205. Finnair Cargo
  • 206. FinSigur
  • 207. First Care Ambulance
  • 208. Fisher BioServices
  • 209. FluidX
  • 210. Force Logistics
  • 211. FOSTER Refrigerator
  • 212. Franzosini
  • 213. Freight Lines
  • 214. FreightWaves
  • 215. Fresenius Kabi
  • 216. Freshliance Electronics
  • 217. GAC
  • 218. Gary Heer Transport
  • 219. Gati
  • 220. Gati Kausar
  • 221. Gavi
  • 222. GE Healthcare
  • 223. GENCO Distribution System
  • 224. Genentech
  • 225. Genomic and Immunotherapy Medical Institute
  • 226. Genzyme
  • 227. GEODIS
  • 228. Georgia Institute of Technology
  • 229. Georgia Research Alliance
  • 230. Georgian Express Special
  • 231. Gilead Sciences
  • 232. Giostyle
  • 233. GlaxoSmithKline
  • 234. Global Cold Chain Alliance
  • 235. Global Cold Chain Solutions
  • 236. Godrej & Boyce
  • 237. Gold Cold Transport
  • 238. GP Logistics
  • 239. Gradalis
  • 240. Greenwich Biosciences
  • 241. Grieshaber
  • 242. Guangdong Haiou Medical Apparatus
  • 243. H.Essers
  • 244. H. Lee Moffitt Cancer Center & Research Institute
  • 245. Haier Bio-Medical and Laboratory
  • 246. HAVI
  • 247. Heat Biologics
  • 248. Heaven Sent Couriers
  • 249. Helapet
  • 250. Helix Research Center
  • 251. Helm Medical
  • 252. Helmer Scientific
  • 253. Helsinn Healthcare
  • 254. Hindustan Syringes & Medical Devices
  • 255. Honeywell International
  • 256. IBM
  • 257. Institut Georges Lopez
  • 258. Igloo Thermo-Logistics
  • 259. iMedical Austria
  • 260. IMP
  • 261. Immunitor
  • 262. INFINITECH INDIA
  • 263. Infistics Solutions
  • 264. INKBIRD
  • 265. Inseltrade
  • 266. IntelliQuick Delivery
  • 267. Intercept Pharmaceuticals
  • 268. Interlink Courier Services
  • 269. Intermountain Life Flight
  • 270. International Company for Medical Necessities
  • 271. Interstate Cold Storage
  • 272. Iovance Biotherapeutics
  • 273. Ironwood Pharmaceuticals
  • 274. Janssen Biotech
  • 275. Jazz Pharmaceuticals
  • 276. Jiangxi Hongda Medical Equipment Group
  • 277. Jiangxi Sanxin Medtec
  • 278. Jigsaw Medical
  • 279. JJX Logistics
  • 280. JMI Syringes & Medical Devices
  • 281. Jones Packaging
  • 282. Juno Therapeutics
  • 283. KAI Pharmaceuticals
  • 284. Kalibox
  • 285. KCAS Bioanalytical Services and Biomarker Services
  • 286. Kenco Group
  • 287. Keppel Logistics
  • 288. Kerry Logistics
  • 289. Kaspect
  • 290. Khaas Logistics
  • 291. Kite Pharma
  • 292. KN PharmaChain
  • 293. Kospa Logistic Services
  • 294. Kuehne + Nagel International
  • 295. KWE Global Logistics Partner
  • 296. Kythera Biopharmaceuticals
  • 297. L&M Transportation Services
  • 298. La Jolla Pharmaceutical
  • 299. Lamprecht Transport
  • 300. LARION
  • 301. Lateral emSoft
  • 302. Lattice Biologics
  • 303. Lettuce Box
  • 304. Lexicon Pharmaceuticals
  • 305. LifeConEx
  • 306. Lifeline Scientific
  • 307. LifeScience Logistics
  • 308. LifeSouth Community Blood Centers
  • 309. Lincs Medical Services
  • 310. Lisaline Lifescience Technologies
  • 311. LogTag Recorders
  • 312. Lufthansa Cargo
  • 313. Lupin
  • 314. LyddAir
  • 315. Lynden International Logistics
  • 316. Mandai Link Logistics
  • 317. Marken
  • 318. Masters Speciality Pharma
  • 319. Massachusetts General Hospital
  • 320. MaxiTrack Sensors
  • 321. Mayo Clinic
  • 322. McArdle Skeath
  • 323. McKesson
  • 324. McLanachan Transport
  • 325. MD Anderson Cancer Center
  • 326. MD Logistics
  • 327. MD Stem Cells
  • 328. MDS Logistics
  • 329. MedCision
  • 330. MediBest Group
  • 331. Medical-Moves
  • 332. Medical Intertrade
  • 333. Medicines Development for Global Health
  • 334. Melinta Therapeutics
  • 335. Merck
  • 336. MeshWorks Wireless
  • 337. MET Medical
  • 338. MethodologyMatch
  • 339. Micro Q Technologies
  • 340. Mile High Ambulance
  • 341. Millennium Pharmaceuticals
  • 342. MILS Cold Chain Logistics
  • 343. Mitra Rajawali Banjaran
  • 344. Mitsubishi Tanabe Pharma
  • 345. MNX Global Logistics
  • 346. Morphotek
  • 347. Mymetics
  • 348. NantKwest
  • 349. National Cancer Institute
  • 350. National Cell Manufacturing Consortium
  • 351. National Centre for Control of Vaccines and Biologicals
  • 352. National Institute of Allergy and Infectious Diseases
  • 353. National Institute of Hygiene and Epidemiology
  • 354. National Heart, Lung, and Blood Institute
  • 355. National Institutes of Health
  • 356. National Institute of Standards and Technology
  • 357. Neomedic
  • 358. Neurocrine Biosciences
  • 359. New York Blood Center
  • 360. NexG
  • 361. Nexleaf Analytics
  • 362. NextPakk
  • 363. Nichirei Logistics Group
  • 364. Nilkamal
  • 365. Nohla Therapeutics
  • 366. NORA
  • 367. Nordic Cold Storage
  • 368. Northern Alliance Advanced Therapies Treatment Centre
  • 369. Novartis
  • 370. Novo Nordisk
  • 371. NPS Pharmaceuticals
  • 372. One Network Enterprises
  • 373. Oneject
  • 374. OpenPort
  • 375. Optimize Courier
  • 376. Organ Recovery Systems
  • 377. Organ Transport Systems
  • 378. ORGANE LOGISTIQUE
  • 379. Organogenesis
  • 380. Organon International
  • 381. Otsuka Pharmaceutical
  • 382. Pacific Bio-Material Management
  • 383. Pa-Hu
  • 384. Paladin Labs
  • 385. Pan Asia Logistics
  • 386. Panalpina
  • 387. Paragonix Technologies
  • 388. Parazelsus
  • 389. Parekh Integrated Services
  • 390. PAREXEL
  • 391. PATH
  • 392. PC Medical Support Services
  • 393. PDP Couriers
  • 394. PDQ Couriers
  • 395. Pelican BioThermal
  • 396. Pfenning Logistics
  • 397. Pfizer
  • 398. Pharma Premier Logistics
  • 399. PharmaJet
  • 400. PharmaServ Express
  • 401. Pharmaserv Logistics
  • 402. Phil Med Alliance
  • 403. Piramal Imaging
  • 404. Polar Thermal
  • 405. POLYNOR
  • 406. Porkka
  • 407. Portola Pharmaceuticals
  • 408. PostNL Belgium
  • 409. Priority Solutions International
  • 410. Prodlekpol
  • 411. ProMab Biotechnologies
  • 412. Protek Pharma Worldwide
  • 413. PTC Therapeutics
  • 414. Puma Biotechnology
  • 415. Purolator
  • 416. Qatari German Company for Medical Devices
  • 417. QCMedchain
  • 418. QPCON
  • 419. Quick International Courier
  • 420. QuickSTAT
  • 421. Raaziq International
  • 422. Radius Health
  • 423. Raes Pharmaceutical Logistics
  • 424. Raghava Warehousing & Logistic Services
  • 425. RALU Logistics
  • 426. REFCOLD India
  • 427. ReFlow
  • 428. Regeneron Pharmaceuticals
  • 429. Relypsa
  • 430. Remonsys
  • 431. Rempex Pharmaceuticals
  • 432. Retractable Technologies
  • 433. Retro Culture
  • 434. Retrophin
  • 435. REVA
  • 436. Revital Healthcare
  • 437. Rhenus Logistics
  • 438. Rigel Pharmaceuticals
  • 439. Roambee
  • 440. Roche
  • 441. Rogue Transportation
  • 442. Royal Group
  • 443. RURO
  • 444. Safeguard Medical Services
  • 445. SameDay Logistics
  • 446. Sanaria
  • 447. Sanofi
  • 448. Sarepta Therapeutics
  • 449. SAVSU Technologies
  • 450. SCALE AI
  • 451. Schechter Tech
  • 452. SciSafe
  • 453. SEKO Worldwide
  • 454. Sensitech
  • 455. Sentry Biopharma Services
  • 456. Seo Chemical
  • 457. Sequel Logistics
  • 458. SF Express
  • 459. Sharif Tarasheh
  • 460. Shionogi
  • 461. ShipChain
  • 462. Shire
  • 463. Sidney Kimmel Comprehensive Cancer Center
  • 464. Sierra Molecular
  • 465. SIGA Technologies
  • 466. Sinobioway Cell Therapy
  • 467. Sinopharm Logistics
  • 468. Sky Fresh
  • 469. SkyCell
  • 470. Smurfit Kappa Lagamill
  • 471. Snowman Logistics
  • 472. SNZOR
  • 473. Sofrigam
  • 474. Sol-Millennium Medical Group
  • 475. South Medical Jets
  • 476. Spark Therapeutics
  • 477. Spectrum Pharmaceuticals
  • 478. Sprout Pharmaceuticals
  • 479. SS Supply Chain Solutions
  • 480. SSG UK Specialist Ambulance Service
  • 481. SSM Health Cardinal Glennon Children's Hospital
  • 482. Star Service
  • 483. Stellapps Technologies
  • 484. Stellar Value Chain Solutions
  • 485. Stemedica Cell Technologies
  • 486. Strongbridge Biopharma
  • 487. Sun Pharma Global
  • 488. SunDanzer Refrigeration
  • 489. Supply Today
  • 490. SwanLeap
  • 491. Sweetbridge
  • 492. Swift Cold Chain Group
  • 493. Swire Cold Chain Logistics
  • 494. Swire Cold Storage
  • 495. Swisslog Holding
  • 496. Switrace
  • 497. Synergy Pharmaceuticals
  • 498. TAG Sensors
  • 499. Taiho Oncology
  • 500. TaiMed Biologics
  • 501. Takeda Pharmaceutical
  • 502. Taylor-Wharton
  • 503. Transport Corporation of India
  • 504. TCP Logistics
  • 505. Tej Couriers
  • 506. Temperature Sensitive Solutions
  • 507. Temperature@lert
  • 508. TempSen Electronics
  • 509. Temptime
  • 510. TESARO
  • 511. Teva Pharmaceutical
  • 512. Thaddeus Medical Systems
  • 513. The Alliance
  • 514. The Medicines Company
  • 515. Therapak
  • 516. Thermo Fisher Scientific
  • 517. TiGenix
  • 518. Tiger Logistics
  • 519. Time Definite Services
  • 520. time:matters
  • 521. Timestrip
  • 522. TLX Cargo
  • 523. TNT Express
  • 524. Tonnindo Eramulya
  • 525. Touchdown International
  • 526. TOWER Cold Chain Solutions
  • 527. TrakCel
  • 528. TransMedics
  • 529. Transplanning
  • 530. Trinity Air Ambulance International
  • 531. Trinity Air Medical
  • 532. Tripharma Logistics
  • 533. TVS Asianics
  • 534. Ultragenyx Pharmaceutical
  • 535. Union Chimique Belge
  • 536. United Network for Organ Sharing
  • 537. United Parcel Service
  • 538. United Therapeutics
  • 539. United Drug Distributors
  • 540. University of Alabama
  • 541. University of Oxford
  • 542. University of Pennsylvania
  • 543. Unsworth Global Logistics
  • 544. Upperton Pharma Solutions
  • 545. U.S. Army Medical Research and Materiel Command
  • 546. US WorldMeds
  • 547. Valeant Pharmaceuticals
  • 548. Validated Delivery Solutions
  • 549. Vanda Pharmaceuticals
  • 550. va-Q-tec
  • 551. VCK Logistics
  • 552. Venz Express
  • 553. Vericel
  • 554. VersaCold Logistics Services
  • 555. Vertex Pharmaceuticals
  • 556. Vesco-MTO
  • 557. Vestfrost
  • 558. Vetter Pharma
  • 559. Vietnam Medical Equipment
  • 560. VTS
  • 561. Walgreens
  • 562. Wayocom Labs
  • 563. Woodfield Distribution
  • 564. Wellstat Therapeutics
  • 565. World Courier
  • 566. Worthington Industries
  • 567. Wuxi Yushou Medical Applicances
  • 568. Wyeth
  • 569. X2 Cold Chain
  • 570. XPO Logistics
  • 571. Yourway Transport
  • 572. Yusen Logistics
  • 573. ZacPak
  • 574. Zebraxx
  • 575. Zero Appliances
  • 576. Zeusch Aviation
  • 577. Zhendre
  • 578. Zhuhai Eastsun Technology
  • 579. ZillionSource Technologies
  • 580. Zipline
  • 581. Zuellig Pharma
Back to Top